Follett, K.A., Boortz-Marx, R.L., Drake, J.M., et al. Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections. Anesthesiology. 2004;100(6):1582–1594.

Fong, C.C., Kwan, A. Patient-controlled sedation using remifentanil for third molar extraction. Anaesthesia and Intensive Care. 2005;33(1):73–77.

Fong, H.K., Sands, L.P., Leung, J.M. The role of postoperative analgesia in delirium and cognitive decline in elderly patients: A systematic review. Anesthesia and Analgesia. 2006;102(4):1255–1266.

Forster, J.G., Rosenberg, P.H. Small dose of clonidine mixed with low-dose ropivacaine and fentanyl for epidural analgesia after total knee arthroplasty. British Journal of Anaesthesia. 2004;93(5):670–677.

Foss, N.B., Kristensen, M.T., Kristensen, B.B., et al. Effect of postoperative epidural analgesia on rehabilitation and pain after hip fracture surgery. Anesthesiology. 2005;102(6):1197–1204.

Foster, A., Mobley, E., Wang, Z. Complicated pain management in a CYP450 2D6 poor metabolizer. Pain Practice. 2007;7(4):352–356.

Fournier, R., Weber, A., Gamulin, Z. Intrathecal sufentanil is more potent than intravenous for postoperative analgesia after total hip replacement. Regional Anesthesia and Pain Medicine. 2005;30(3):249–254.

Fragen, R.J., Vilich, F., Spies, S.M., et al. The effect of remifentanil on biliary tract drainage into the duodenum. Anesthesia and Analgesia. 1999;89(6):1561–1564.

Fredheim, O.M., Moksnes, K., Borchgrevink, P.C., et al. Clinical pharmacology of methadone for pain. Acta Anaesthesiologica Scandinavica. 2008;52(7):879–889.

Freye, E. Opioids in medicine. The Netherlands: Springer, 2008.

Frolich, M., Giannotti, A., Modell, J.H. Opioid overdose in a patient using a fentanyl patch during treatment with a warming blanket. Anesthesia and Analgesia. 2001;93(3):647–648.

Fromm, M.F., Eckhardt, K., Li, S., et al. Loss of analgesic effect of morphine due to coadministration of rifampin. Pain. 1997;72(1, 2):261–267.

Fujii, Y., Saitoh, Y., Tanaka, H., et al. Granisetron/dexamethasone combination for reducing nausea and vomiting during and after spinal anesthesia for cesarean section. Anesthesia and Analgesia. 1999;88(6):1346–1350.

Fukuda, K. Intravenous opioid anesthetics. (2005). In: Miller R.D., ed. Miller’s anesthesia. 6th ed. St. Louis: Churchill Livingstone; 2005:379–437.

Furlan, A., Lakha, S.F., Yegneswaran, B., et al. A systematic review of the effects of opioids on driving and working performances. Pain Research & Management. 2007;12:126–127. [Poster presented at Canadian Pain Society Conference, May, 2007, Ottawa, Ontario].

Furlan, A.D., Sandoval, J.A., Mailis-Gagnon, A., et al. Opioids for chronic noncancer pain: A meta-analysis of effectiveness and side effects. Canadian Medical Association Journal. 2006;174(11):1589–1594.

Gabrail, N.Y., Dvergsten, C., Ahdieh, H. Establishing the dosage equivalency of oxymorphone extended release and oxycodone controlled release in patients with cancer pain: A randomized controlled study. Current Medical Research and Opinion. 2004;20(6):911–918.

Gaertner, J., Radbruch, T., Giesecke, H., et al. Assessing cognition and psychomotor function under long-term treatment with controlled release oxycodone in non-cancer patients. Acta Anesthesiologica Scandinavica. 2006;50(6):664–672.

Gagliese, L., Gauthier, L.R., Macpherson, A.K., et al. Correlates of postoperative pain and intravenous patient-controlled analgesia use in younger and older surgical patients. Pain Medicine (Malden, Mass.). 2008;9(3):299–314.

Gagliese, L., Jackson, M., Ritvo, P., et al. Age is not an impediment to effective use of patient-controlled analgesia by surgical patients. Anesthesiology. 2000;93(3):601–610.

Gagnon, P., Allard, P., Masse, B., et al. Delirium in terminal cancer: A prospective study using daily screening, early diagnosis, and continuous monitoring. Journal of Pain and Symptom Management. 2000;19(6):412–426.

Gallagher, P.F., Barry, P.J., Ryan, C., et al. Inappropriate prescribing in an acutely ill population of elderly patients as determined by Beers’ Criteria. Age and Ageing. 2008;37(1):96–101.

Gallagher, R.E., Arndt, D.R., Hunt, K.L. Analgesic effects of topical methadone: A report of four cases. The Clinical Journal of Pain. 2005;21(2):190–192.

Gallagher, R.M., Welz-Bosna, M., Gammaitoni, A. Assessment of dosing frequency of sustained-release opioid preparations in patients with chronic nonmalignant pain. Pain Medicine (Malden, Mass.). 2007;8(1):71–74.

Gallagher, S.F., Haines, K.L., Osterlund, L.G., et al. Postoperative hypoxemia: Common, undetected, and unsuspected after bariatric surgery. The Journal of Surgical Research. 2010. [doi:10.1016/j.jss.2009.09.003].

Galski, T., Williams, J.B., Ehle, H.T. Effects of opioids on driving ability. Journal of Pain and Symptom Management. 2000;19(3):200–208.

Gambling, D., Hughes, T., Martin, G., et al. A comparison of DepoDur, a novel, single-dose extended-release epidural morphine with conventional, preservative-free epidural morphine for pain relief after lower abdominal surgery. Anesthesia and Analgesia. 2005;100(4):1065–1074.

Gan, T.J. Postoperative nausea and vomiting—can it be eliminated? JAMA: The Journal of the American Medical Association. 2002;287(10):1233–1236.

Gan, T.J. Risk factors for postoperative nausea and vomiting. Anesthesia and Analgesia. 2006;102(6):1884–1898.

Gan, T.J., Coop, A., Philip, B.K., et al. A randomized, double-blind study of granisetron plus dexamethasone versus ondansetron plus dexamethasone to prevent postoperative nausea and vomiting in patients undergoing abdominal hysterectomy. Anesthesia and Analgesia. 2005;101(5):1323–1329.

Gan, T.J., Franiak, R., Reeves, J. Ondansetron orally disintegrating tablet versus placebo for the prevention of postdischarge nausea and vomiting after ambulatory surgery. Anesthesia and Analgesia. 2002;94(5):1199–1200.

Gan, T.J., Jiao, K.R., Zenn, M., et al. A randomized controlled comparison of electro-acupoint stimulation or ondannsetron versus placebo for the prevention of postoperative nausea and vomiting. Anesthesia and Analgesia. 2004;99(4):1070–1075.

Gan, T.J., Meyer, T., Apfel, C.C., et al. Consensus guidelines for managing postoperative nausea and vomiting. Anesthesia and Analgesia. 2003;97(1):62–71.

Gan, T.J., Meyer, T., Apfel, C.C., et al. Society for Ambulatory Anesthesia guidelines for the management of postoperative nausea and vomiting. Anesthesia and Analgesia. 2007;105(6):1615–1628.

Gan, T.J., Sinha, A.C., Kovac, A.L., et al. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting. Anesthesia and Analgesia. 2009;108(5):1498–1504.

Gan, T.J., Sloan, F., de L Dear, G., et al. How much are patients willing to pay to avoid postoperative nausea and vomiting? Anesthesia and Analgesia. 2001;92(2):393–400.

Gan, T.J., White, P.F., Scuderi, P.E., et al. FDA “Black Box” warning regarding use of droperidol for postoperative nause and vomiting: Is it justified? (Letter). Anesthesiology. 2002;97(1):287.

Ganesh, A., Maxwell, L.G. Pathophysiology and management of opioid-induced pruritus. Drugs. 2007;67(6):2323–2333.

Gannon, R.H. Current strategies for preventing or ameliorating postoperative ileus: A multimodal approach. American Journal of Health-System Pharmacy: AJHP. 2007;64(20 Suppl. 13):S8–S12.

Gardner-Nix, J. Oral methadone for managing chronic nonmalignant pain. Journal of Pain and Symptom Management. 1996;11(5):321–328.

Gardner-Nix, J. Oral transmucosal fentanyl and sufentanil for incident pain. (Letter). Journal of Pain and Symptom Management. 2001;22(2):627–629.

Gardner-Nix, J. Caregiver toxicity from transdermal fentanyl. (Letter). Journal of Pain and Symptom Management. 2001;21(6):447–448.

Gardner-Nix, J., Mercadante, S. The role of OROS hydromorphone in the management of cancer pain. Pain Practice. 2010;10(1):72–77.

Gasche, Y., Daali, Y., Fathi, M., et al. Codeine intoxication associated with ultrarapid CYP2D6 metabolism. The New England Journal of Medicine. 2004;351(27):2827–2831.

Gaskell, H., Derry, S., Moore, R.A., et al. Single dose oral oxycodone and oxycodone plus paracetamol (acetaminophen) for acute postoperative pain in adults. Cochrane Database of Systematic Reviews (Online). (3):2009. [CD002763].

Gasse, C., Derby, L., Vasilakis-Scaramozza, C., et al. Incidence of first-time idiopathic seizures in users of tramadol. Pharmacotherapy. 2000;20(6):629–634.

Gautier, P.E., Debry, F., Fanard, L., et al. Ambulatory combined spinal-epidural analgesia for labor: Influence of epinephrine on bupivacaine-sufentanil combination. Regional Anesthesia. 1997;22(2):143–149.

Gharagozlou, P., Hashemi, E., DeLorey, T.M., et al. Pharmacological profiles of opioid ligands at kappa opioid receptors. BMC Pharmacology. 2006;6:3.

Ghori, M.K., Zhang, Y.F., Sinatra, R.S. Pathophysiology of acute pain. In: Sinatra R.S., de Leon-Casasola O.A., Ginsberg B., Viscusi E.R., eds. Acute pain management. Cambridge, New York: Cambridge University Press; 2009:21–32.

Gianino, J.M., York, M.M., Paice, J.A. Intrathecal drug therapy for spasticity and pain. New York: Springer, 1996.

Gibbison, B., Spencer, R. Post-operative nausea and vomiting. Anaesthesia and Intensive Care Medicine. 2009;10(12):583–585.

Gilron, I. Analgesia controlled with patience: Towards a better understanding of analgesic self-administration behaviour. Canadian Journal of Anesthesia. 2008;55(2):75–81.

Gilron, I., Bailey, J.M., Tu, D., et al. Morphine, gabapentin, or their combination for neuropathic pain. The New England Journal of Medicine. 2005;352(13):1324–1334.

Gimbel, J.S., Ahdieh, H. The efficacy and safety of oral immediate-release oxymorphone for postsurgical pain. Anesthesia and Analgesia. 2004;99(5):1472–1477.

Gimbel, J.S, Richards, P., Portenoy, R.K. Controlled-release oxycodone for pain in diabetic neuropathy. A randomized controlled trial. Neurology. 2003;60(6):927–934.

Gimbel, J.S., Walker, D., Ma, T., et al. Efficacy and safety of oxymorphone immediate release for the treatment of mild to moderate pain after ambulatory orthopedic surgery: Results of a randomized, double-blind, placebo-controlled trial. Archives of Physical Medicine and Rehabilitation. 2005;86(12):2284–2289.

Ginsberg, B., Cohen, N.A., Ossey, K.D., et al. The use of PCA to assess the influence of demographic factors on analgesic requirements. Anesthesiology. 1989;71:A688. [(abstract)].

Ginsberg, B., Sinatra, R.S., Adler, L.J., et al. Conversion to oral controlled-release oxycodone from intravenous opioid analgesic in the postoperative setting. Pain Medicine (Malden, Mass.). 2003;4(1):31–38.

Glare, P., Walsh, D., Sheehan, D. The adverse effects of morphine: A prospective survey of common symptoms during repeated dosing for chronic pain. The American Journal of Hospice & Palliative Care. 2006;23(3):229–235.

GlaxoSmithKline. Entereg prescribing information. Research Triangle Park, NC: GlaxoSmithKline, 2009.

Goldberg, M., Vatashsky, E., Haskel, Y., et al. The effect of meperidine on the guinea pig extrahepatic biliary tract. Anesthesia and Analgesia. 1987;66(12):1282–1286.

Gold Standard Clinical Pharmacology Relistor monograph, 2009. Available at http://clinicalpharmacology.com/Forms/Monograph/monograph.aspx?cpnum=3386&sec=monindi. [Accessed August 19, 2009].

Golembiewski, J.A. Morphine and hydromorphone for postoperative analgesia: Focus on safety. Journal of Perianesthesia Nursing. 2003;18(2):120–122.

Golembiewski, J.A., Chernin, E., Chopra, T. Prevention and treatment of postoperative nausea and vomiting. American Journal of Health-System Pharmacy. 2005;62(5):1247–1262.

Golf, M., Robson, M., Pollak, R., et al. Paper presented at American Academy of Pain Medicine Annual Meeting, Orlando, Florida, February 12–16. Safety and efficacy of 12-hour controlled-release hydrocodone/acetaminophen for acute pain following bunionectomy: A phase 3, randomized, multi-center, double-blind study, 2008.

Goll, V., Akca, O., Grief, R., et al. Ondansetron is no more effective than supplemental intraoperative oxygen for prevention of postoperative nausea and vomting. Anesthesia and Analgesia. 2001;92(1):112–117.

Goodfriend, B. Slap down injection discomfort. Consultant. 1987;27:154.

Goodheart, C.R., Leavitt, S.B., Managing opioid-induced constipation in ambulatory-care patients. Pain Treatment Topics 2006. Available at http://pain-topics.org/pdf/Managing_Opioid-Induced_Constipation.pdf [#search=“constipation”. Accessed July 28, 2007].

Goodman, M., Low, J., Wilkinson, S. Constipation management in palliative care: A survey of practices in the United Kingdom. Journal of Pain and Symptom Management. 2005;29(3):238–244.

Goodwin, K., Kim, N.H., Zuniga, R. Stability of a baclofen and clonidine hydrochloride admixture for intrathecal administration. Hospital pharmacy. 2001;36(9):950–954.

Gordon, A.F., Levine, J.D., Dubois, M.Y., et al. Open-label exploration of an intravenous nalbuphine and naloxone mixture as an analgesic agent following gynecologic surgery. Pain Medicine (Malden, Mass.). 2007;8(6):525–530.

Gordon, D. Hydroxyzine doesn’t “help” opioids. The American Journal of Nursing. 1995;95(8):20.

Gordon, D.B. Oral transmucosal fentanyl citrate for cancer breakthrough pain: A review. Oncology Nursing Forum. 2006;33(2):257–264.

Gordon, D.B., Continuous infusion subcutanous morphine. Personal email communication on September, 20, 2008, 2008.

Gordon, D.B., Dahl, J., Phillips, P., et al. The use of “as needed” range orders for opioid analgesics in the management of acute pain: A consensus statement from the American Society for Pain Management Nursing and the American Pain Society. Pain Management Nursing. 2004;5(2):53–58.

Gordon, D.B., Jones, H.D., Goshman, L.M., et al. A quality improvement approach to reducing use of meperidine. Joint Commission Journal on Quality and Improvement. 2000;26(12):686–699.

Gordon, D.B., Pellino, T.A., Higgins, G.A., et al. Nurses’ opinions on appropriate administration of PRN range opioid analgesic orders for acute pain. Pain Management Nursing. 2008;9(3):131–140.

Gordon, N.B. The functional status of the methadone maintained person. In: Simmons L.R.S., Gold M.B., eds. Discrimination and the addict. Beverly Hills: Sage Publications; 1973:101–121.

Gottschalk, A. Craniotomy pain: Trying to do better. Anesthesia and Analgesia. 2009;109(5):1379–1381.

Gottschalk, A., Freitag, M., Burmeister, M.A, et al. Patient-controlled thoracic epidural infusion with ropivacaine 0.375% provides comparable pain relief as bupivacaine 0.125% plus sufentanil after major abdominal gynecologic tumor surgery. Regional Anesthesia and Pain Medicine. 2002;27(4):367–373.

Gould, E.M., Jensen, M.P., Victor, T.W., et al. The pain quality response profile of oxymorphone extended release in the treatment of low back pain. The Clinical Journal of Pain. 2009;25(2):116–122.

Gourevitch, M.N. First, do no harm … reduction? Annals of Internal Medicine. 2009;150(6):417–418.

Gourevitch, M.N., Friedland, G.H. Interactions between methadone and medications used to treat HIV infection: A review. The Mount Sinai Journal of Medicine New York. 2000;67(5–6):429–436.

Graf, C., Puntillo, K. Pain in the older adult in the intensive care unit. Critical Care Clinics. 2003;19:749–770.

Gralow, I. Cancer pain: An update of pharmacological approaches in pain therapy. Current Opinion in Anaesthesiology. 2002;15(5):555–561.

Grape, S., Schug, S.A. Epidural and spinal analgesia. In: Macintyre P.E., Walker S.M., Rowbotham D.J., eds. Clinical pain management. Acute pain. London: Hodder Arnold; 2008:255–270.

Grape, S., Tramer, M.R. Do we need preemptive analgesia for the treatment of postoperative pain? Best Practice & Research Clinical Anaesthesiology. 2007;21(1):51–63.

Grass, J.A. Patient-controlled analgesia. Anesthesia and Analgesia. 2005;101(Suppl. 1):S44–S61.

Grauer, P.A., Bass, J., Wenzel, E., et al. A feasibility study of the rectal and vaginal administration of sustained release morphine sulfate tablets for the treatment of cancer-related pain. Proc Am Soc Clin Oncol. 1992;11:1392.

Grover, V.K., Mathew, P.J., Hegde, H. Efficacy of orally disintegrating ondansetron in preventing postoperative nausea and vomiting after laparoscopic cholecystectomy: A randomised, double-blind placebo controlled study. Anaesthesia. 2009;64(6):595–600.

Gruber, E.M., Tschernko, E.M., Kritzinger, M., et al. The effects of thoracic epidural analgesia with bupivacaine 0.25% on ventilatory mechanics in patients with severe chronic obstructive pulmonary disease. Anesthesia and Analgesia. 2001;92(4):1015–1019.

Guay, D.R. Use of oral oxymorphone in the elderly. The Consultant Pharmacist: The Journal of the American Society of Consultant Pharmacists. 2007;22(5):417–430.

Guignard, B., Bossard, A.E., Cost, C., et al. Acute opioid tolerance. Intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology. 2000;93(2):409–417.

Guler, T., Unlugenc, H., Gundogan, Z., et al. A background infusion of morphine enhances patient-controlled analgesia after cardiac surgery. Canadian Journal of Anesthesia. 2004;51(7):718–722.

Gunion, M.W., Marchionne, A.M., Anderson, C.T.M. Use of the mixed agonist antagonist nalbuphine in opioid based analgesia. Acute Pain. 2004;6(1):29–39.

Gupta, A., Fant, F., Axelsson, K., et al. Postoperative analgesia after radical retropublic prostatectomy. Anesthesiology. 2006;105(4):784–793.

Gupta, S., Sathyan, G. Providing constant analgesia with OROS hydromorphone. Journal of Pain and Symptom Management. 2007;33(2S):S19–S24.

Gurkan, Y., Toker, K. Prophylactic ondansetron reduces the incidence of intrathecal fentanyl-induced pruritus. Anesthesia and Analgesia. 2002;96(6):1763–1766.

Gutstein, H.B., Akil, H. Opioid analgesics. In: Brunton L.L., Lazo J.S., Parker K.L., eds. Goodman, Gilman’s the pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill; 2006:547–590.

Habib, A.S., Breen, T.W., Gan, T.J. Promethazine adverse events after implementation of a medication shortage interchange. (Letter). The Annals of Pharmacotherapy. 2005;39(7–8):1370.

Habib, A.S., El-Moalem, H.E., Gan, T.J. The efficacy of the 5-HT3 receptor antagonists combined with droperidol for PONV prophylaxis is similar to their combination with dexamethasone: A meta-analysis of randomized controlled trials. Canadian Journal of Anesthesia. 2004;51(4):311–319.

Habib, A.S., Gan, T.J. Food and Drug Administration Black Box Warning on the perioperative use of droperidol: A review of the cases. Anesthesia and Analgesia. 2003;96(5):1377–1379.

Habib, A.S., Gan, T.J. Evidence-based management of postoperative nausea and vomiting: A review. Canadian Journal ofAnesthesia. 2004;51(4):326–341.

Habib, A.S., Gan, T.J. CON: Postoperative nausea and vomiting database research: Limitations and opportunities. (Editorial). Anesthesia and Analgesia. 2010;110(2):412–414.

Habib, A.S., Reuveni, J., Taguchi, A., et al. A comparison of ondansetron with promethazine for treating postoperative nausea and vomiting in patients who received prophylaxis with ondansetron: A retrospective database analysis. Anesthesia and Analgesia. 2007;104(3):548–551.

Habib, A.S., White, W.D., Eubanks, S., et al. A randomized comparison of a multimodal management strategy versus combination antiemetics for the prevention of postoperative nausea and vomiting. Anesthesia and Analgesia. 2004;99(1):77–81.

Hadi, I., da Silva, O., Natale, R., et al. Opioids in the parturient with chronic nonmalignant pain: A retrospective review. Journal of Opioid Management. 2006;2(1):31–34.

Hagen, N.A., Babul, N. Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer pain. Cancer. 1997;79:1428–1437.

Hagen, N.A., Fisher, K., Stiles, C. Sublingual methadone for the management of cancer-related breakthrough pain: A pilot study. Journal of Palliative Medicine. 2007;10(2):331–337.

Hagen, N.A., Swanson, R. Strychnine-like multifocal myoclonus and seizures in extremely high-dose opioid administration: Treatment strategies. Journal of Pain and Symptom Management. 1997;14(1):51–58.

Hair, P.I., Keating, G.M., McKeage, K. Transdermal matrix fentanyl membrane patch (matrifen): In severe cancer-related chronic pain. Drugs. 2008;68(14):2001–2009.

Hale, M.E., Ahdieh, H., Ma, T., et al. Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: A 12-week, randomized, double-blind, placebo-controlled study. The Journal of Pain. 2007;8(2):175–184.

Hale, M.E., Dvergsten, C., Gimbel, J. Efficacy and safety of oxymorphone extended-release in chronic low back pain: Results of a randomized, double-blind, placebo- and active-controlled study. The Journal of Pain. 2005;6(1):21–28.

Hale, M., Tudor, I.C., Khanna, S., et al. Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: Results of a 6-week, randomized, open-label, noninferiority analysis. Clinical Therapeutics. 2007;29(5):874–888.

Hale, M., Upmalis, D., Okamoto, A., et al. Tolerability of tapentadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: A randomized, double-blind study. Current Medical Research and Opinion. 2009;25(5):1095–1104.

Halker, R.B., Demaerschalk, B.M., Wellik, K.E., et al. Caffeine for the prevention and treatment of postdural puncture headache: Debunking the myth. The Neurologist. 2007;13(5):323–327.

Han, P.K.J., Arnold, R., Bond, G. Myoclonus secondary to withdrawal from transdermal fentanyl: Case report and literature review. Journal of Pain and Symptom Management. 2002;23(1):66–72.

Hanks, G., Cherny, N.I., Fallon, M. Opioid analgesic therapy. In: Doyle D., Hanks G., Cherny N.I., Calman K., eds. Oxford textbook of palliative medicine. 3rd ed. New York: Oxford Press; 2004:316–341.

Hanks, G.W., De Conno, F., Cherny, N., et al. Morphine and alternative opioids in cancer pain: The EAPC recommendations. British Journal of Cancer. 2001;84(5):587–593.

Hanks, G.W., Reid, C. Contribution to variability in response to opioids. Supportive Care in Cancer. 2005;13(3):145–152.

Hanley, M.A., Jensen, M.P., Smith, D.G., et al. Preamputation pain and acute pain predict chronic pain after lower extremity amputation. The Journal of Pain. 2007;8(2):102–109.

Hanna, M.H., Elliott, K.M., Fung, M. Randomized, double-blind study of the analgesic efficacy of morphine-6-glucuronide versus morphine sulfate for postoperative pain in major surgery. Anesthesiology. 2005;102(4):815–821.

Hanna, M., O’Brien, C., Wilson, M.C. Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients. European Journal of Pain (London, England). 2008;12(6):804–813.

Hanna, M., Thipphawong, J., 118 Study Group. A randomized, double-blind comparison of OROS hydromorphone and controlled-release for the control of chronic cancer pain. BMC Palliative Care. 2008;7(1):17.

Hans, G. Buprenorphine—a review of its role in neuropathic pain. Journal Opioid Management. 2007;2(4):195–206.

Hansen, L.A., Noyes, M.A., Lehman, M.E. Evaluation of patient-controlled analgesia (PCA) versus PCA plus continuous infusion in postoperative cancer patients. Journal of Pain and Symptom Management. 1991;6(1):4–14.

Harnett, M.J.P., O’Rourke, N., Walsh, M., et al. Transdermal scopolamine for prevention of intrathecal morphine-induced nausea and vomiting after cesarean delivery. Anesthesia and Analgesia. 2007;105(3):764–769.

Harris, J.D. Management of expected and unexpected opioid-related side effects. The Clinical Journal of Pain. 2008;24(4, Suppl. 10):S8–S13.

Harris, J.D., Kotob, F. de Leon-Casasola, ed. Cancer pain. Pharmacological, interventional and palliative care approaches. Saunders: Philadelphia, 2006:207–234.

Hartrick, C.T., Hartrick, K.A. Extended-release epidural morphine (DepoDur): Review and safety analysis. Expert Review of Neurotherapeutics. 2008;8(11):1641–1648.

Hartrick, C., Van Hove, I., Stegmann, J.U., et al. Efficacy and tolerability of tapentadol immediate release and oxycodone HCL immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: A 10-day, phase III, randomized, double-blind, active- and placebo-controlled study. Clinical Therapeutics. 2009;31(2):260–271.

Hartrick, C.T., Martin, G., Kantor, G., et al. Evaluation of a single-dose extended-release epidural morphine formulation for pain after knee arthroplasty. Journal of Bone and Joint Surgery. 2006;88A(11):271–281.

Hartsell, T., Long, D., Kirsch, J.R. The efficacy of postoperative ondansetron (Zofran®) orally disintegrating tablets for preventing nausea and vomiting after acoustic neuroma surgery. Anesthesia and Analgesia. 2005;101(5):1492–1496.

Hassenbusch, S.J., Portenoy, R.K., Cousins, M., et al. Polyanalgesic consensus conference 2003: An update on the management of pain by intraspinal drug delivery—report of an expert panel. Journal of Pain and Symptom Management. 2004;27(6):540–563.

Hawton, K., Bergen, H., Simkin, S., et al. Effect of withdrawal of co-proxamol on prescribing and deaths from drug poisoning in England and Wales: Time series analysis. BMJ (Clinical Research Ed.). 2009;338:b2270.

Hebl, J.R. The importance and implications of aseptic techniques during regional anesthesia. Regional Anesthesia and Pain Medicine. 2006;31(4):311–323.

Heid, F., Piepho, T., Stengel, S., et al. Premature termination of epidural analgesia—a prospective analysis to improve quality. Acute Pain. 2009;11(3–4):75–81.

Heinomen, O.P., Slone, S., Shapiro, S. Birth defects and drugs in pregnancy. Littleton, MA: Publishing Science Group, 1977.

Heiskanen, T., Matzke, S., Haakana, S., et al. Transdermal fentanyl in cachectic cancer patients. Pain. 2009;144(1–2):218–222.

Heit, H.A., Gourlay, D.L. Buprenorphine: New tricks with an old molecule for pain management. The Clinical Journal of Pain. 2008;24(2):93–97.

Heitz, J.W., Viscusi, E.R. Sinatra R.S., de Leon-Casasola O.A., Ginsberg B., Viscusi E.R, eds. Acute pain management. Cambridge University Press: Cambridge, New York, 2009:323–331.

Helm, J.F., Venu, R.P., Geenen, J.E., et al. Effects of morphine on the human sphincter of Oddi. Gut. 1988;29(10):1402–1407.

Hemmelgarn, B., Suissa, S., Huang, A., et al. Benzodiazepine use and the risk of motor vehicle crash in the elderly. J Am Med Assoc. 1997;278:27–31.

Hemstapat, K., Monteith, G.R., Smith, D., et al. Morphine-3 glucuronide’s neuro-excitatory effects are mediated via indirect activation of N-methyl-D-aspartic acid receptors: Mechanistic studies in embryonic cultured hippocampal neurones. Anesthesia and Analgesia. 2003;97(2):494–505.

Hendler, N., Cimini, C., Long, D. A comparison of cognitive impairment due to benzodiazepines and to narcotics. The American Journal of Psychiatry. 1980;137(7):828–830.

Henry, A., Tetzlaff, J.E., Steckner, K. Ondansetron is effective in treatment of pruritus after intrathecal fentanyl. (Letter). Regional Anesthesia and Pain Medicine. 2002;27(5):538–539.

Herrick, I.A., Ganapathy, S., Komar, W., et al. Postoperative cognitive impairment in the elderly. Anaesthesia. 1996;51:356–360.

Hersh, E.V., Pinto, A., Moore, P.A. Adverse drug interactions involving common prescription and over-the-counter analgesic agents. Clinical Therapeutics. 2007;29(Suppl.):2477–2497.

Hess, P., Aleshi, P. Pain in pregnancy, childbirth, and the puerperium. In: Macintyre P.E., Walker S.M., Rowbotham D.J., eds. Acute pain. 2nd ed. London, UK: Hodder Arnold; 2008:460–476.

Hewitt, D.J. The Brietbart, et al article reviewed. Oncology. 2000;14(5):705–710.

Hewitt, D.J., Todd, K.H., Xiang, J., et al. Tramadol/acetaminophen or hydrocodone/acetaminophen for the treatment of ankle sprain: A randomized, placebo-controlled trial. Annals of Emergency Medicine. 2007;49(4):468–480.

Hicks, R.W., Heath, M., Sikirica, V., et al. Medication errors involving patient-controlled analgesia. Joint Commission Journal on Quality and Patient Safety/Joint Commission Resources. 2008;34(12):734–742.

Hildebrand, K.R., Elsberry, D.E., Anderson, V.C. Stability and compatibility of hydromorphone hydrochloride in an implantable infusion system. Journal of Pain and Symptom Management. 2001;22(6):1042–1047.

Hildebrand, K.R., Elsberry, D.D., Deer, T.R. Stability, compatibility, and safety of intrathecal bupivacaine administered chronically via an implantable delivery system. The Clinical Journal of Pain. 2001;17(3):238–244.

Hildebrand, K.R., Elsberry, D.D., Hassenbusch, S.J. Stability and compatibility of morphine—clonidine admixtures in an implantable infusion system. Journal of Pain and Symptom Management. 2003;25(5):464–471.

Hillman, H., Jarman, D. Freezing skin. Nursing times. 1986;82:40–41.

Hinrichs, M., Huseboe, J. Research-based protocol: Management of constipation. Journal of Gerontology Nursing. 2001;27(2):17–28.

Ho, K.T., Gan, T.J. Opioid-related adverse effects and treatment options. In: Sinatra R.S., de Leon-Casasola O.A., Ginsberg B., Viscusi E.R., eds. Acute pain management. Cambridge: New York, Cambridge University Press; 2009:406–415.

Ho, T., Vrabec, J.T., Burton, A.W. Hydrocodone use and sensorineural hearing loss. Pain Physician. 2007;10(3):467–472.

Hodgson, P.S., Liu, S.S. A comparison of ropivacaine with fentanyl to bupivacaine with fentanyl for postoperative patient-controlled epidural analgesia. Anesthesia and Analgesia. 2001;92(4):1024–1028.

Hodgson, P.S., Neal, J.M., Pollock, J.E., et al. The neurotoxicity of drugs given intrathecally (spinal). Anesthesia and Analgesia. 1999;88(4):798–809.

Hogan, J. Why don’t nurses monitor the respiratory rate of patients? British Journal of Nursing (Mark Allen Publishing). 2006;15(9):489–492.

Hoke, J.F., Shlugman, D., Dershwitz, M., et al. Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers. Anesthesiology. 1997;87:533–541.

Holmfred, A., Vikersfors, T., Berggren, L., et al. Intrathecal catheters with subcutaneous port systems in patients with severe cancer-related pain managed out of hospital: The risk of infection. Journal of Pain and Symptom Management. 2006;31(6):568–572.

Holmquist, G. Opioid metabolism and effects of cytochrome P450. Pain Medicine (Malden, Mass.). 2009;10(Suppl. 1):S20–S29.

Holt, D.V., Viscusi, E.R., Wordell, C.J. Extended-duration agents for perioperative pain management. Current pain and Headache Reports. 2007;11(1):33–37.

Holte, K., Kehlet. Postoperative ileus: Progress towards effective management. Drugs. 2002;62(18):2603–2615.

Hong, D., Flood, P., Diaz, G. The side effects of morphine and hydromorphone patient-controlled analgesia. Anesthesia and Analgesia. 2008;107(4):1384–1389.

Horlocker, T.T., Wedel, D.J. Regional anesthesia in the immunocompromised patient. Regional Anesthesia and Pain Medicine. 2006;31(4):334–345.

Huang, P., Kehner, G.B., Cowan, A., et al. Comparison of pharmacological activities of buprenorphine and norbuprenorphine: Norbuprenorphine is a potent opioid agonist. Journal of Pharmacology and Experimental Therapeutics. 2001;297(2):688–695.

Huang, Y.S., Lin, L.C., Huh, B.K., et al. Epidural clonidine for postoperative pain after total knee arthroplasty: A dose-response study. Anesthesia and Analgesia. 2007;104(5):1230–1235.

Huang, Y.M., Wang, C.M., Wang, C.T., et al. Perioperative celebrex administration for pain management after total knee arthroplasty—A randomized, controlled study. BMC Musculoskeletal Disorders. 2008;9:77.

Hubbard, G.P., Wolfe, K.R. Meperidine misuse in a patient with sphincter of Oddi dysfunction. The Annals of Pharmacotherapy. 2003;37(4):534–537.

Hudcova, J., McNicol, E.D., Quah, C.S., et al. Patient controlled opioid analgesia versus conventional opioid analgesia for postoperative pain. Cochrane Database of Systematic Reviews (Online). (4):2006. [CD003348].

Hudziak, B. Contralateral ice massage during bone marrow aspiration. PRN Forum. 1983;2:5.

Hum, A., Fainsinger, R.L., Bielech, M. Subcutaneous methadone—An issue revisited. Journal of Pain and Symptom Management. 2007;34(6):573–575.

Hunt, R., Fazekas, B., Thorne, D., et al. A comparison of subcutaneous morphine and fentanyl in hospice cancer patients. Journal of Pain and Symptom Management. 1999;18:111–119.

Hutchison, R.W., Chon, E.H., Tucker, W.F., et al. A comparison of a fentanyl, hydromorphone, and morphine patient-controlled intravenous delivery for acute postoperative analgesia: A multicenter study of opioid-induced adverse effects. The American Journal of Nursing. 2006;41(7):659–663.

Iatrou, C.A., Dragoumanis, C.K., Vogiatzaki, T.D., et al. Prophylactic intravenous ondansetron and dolasetron in intrathecal morphine-induced pruritus: A randomized, double-blinded, placebo-controlled study. Anesthesia and Analgesia. 2005;101(5):1516–1520.

Iijima, T., Ishiyama, T., Kashimoto, S., et al. A comparison of three different concentrations if ropivacaine with fentanyl for patient-controlled analgesia. Anesthesia and Analgesia. 2007;105(2):507–511.

Indelicato, R.A., Portenoy, R.K. Opioid rotation in the management of refractory cancer pain. Journal of Clinical Oncology. 2002;20(1):348–352.

Inouye, S.M., van Dyck, C., Alessi, C., et al. Clarifying confusion: The confusion assessment method. Annals of Internal Medicine. 1990;113(12):941–948.

Institute for Safe Medication Practices (ISMP), Safety issues with patient-controlled analgesia. Part I. ISMP Medication Safety Alert!, 2003;8(14):1–3. http://www.ismp.org/Newsletters/acutecare/articles/20030710.asp [Accessed July 30, 2003].

Institute for Safe Medication Practices (ISMP), Safety issues with patient-controlled analgesia. Part II. ISMP Medication Safety Alert!, 2003;8(15):1–3. Available at http://www.ismp.org/Newsletters/acutecare/articles/20030724.asp [Accessed July 30, 2003].

Institute for Safe Medication Practices (ISMP), How fast is too fast for IV push medications? ISMP Medication Safety Alert!, 2003;8(11):1–2. Available at http://www.ismp.org/Newsletters/acutecare/articles/20030515.asp [Accessed May 6, 2005].

Institute for Safe Medication Practices (ISMP), An omnipresent risk of morphine hydromorphone mix-ups. ISMP Medication Safety Alert!, 2004;8(15):1–3. Available at http://www.ismp.org/Newsletters/acutecare/articles/20040701.asp [Accessed April 4, 2008].

Insititue for Safe Medication Practices (ISMP). Misprogram a PCA pump? It’s easy!. ISMP Medication Safety Alert!. 2004;9(15):1–2.

Institute for Safe Medication Practices (ISMP), The five rights cannot stand alone. Nurse-Advise ERR, 2004;2(11):1. Available at http://www.ismp.org/Newsletters/nursing/Issues/NurseAdviseERR200411.pdf [Accessed September 4, 2009].

Institute for Safe Medication Practices (ISMP). Action needed to prevent serious tissue injury with IV promethazine. ISMP Medication Safety Alert!. 2006;4(6):1–2.

Institute for Safe Medication Practices (ISMP). Promethazine survey spurs renewed efforts to prevent tissue injury. ISMP Medication Safety Alert!. 2006;4(6):1–2.

Institute for Safe Medication Practices (ISMP), Reducing patient harm from opiates. ISMP Medication Safety Alert! Acute Care Edition 2007. Available at http://www.ismp.org/Newsletters/acutecare/articles/20070222.asp

Institute for Safe Medication Practices (ISMP), Keeping patients safe from iatrogenic methadone overdoses. ISMP Medication Safety Alert: Acute Care Edition 2008. Available at http://www.ismp.org/newsletters/acutecare/ articles/20080214.asp [Accessed July 31, 2009].

Institute for Safe Medication Practices (ISMP). Various release formulations of oral opioids confusion. ISMP Medication Safety Alert! Nurse Advise-ERR. 2009;7(3):1–3.

Insititue for Safe Medication Practices (ISMP). Intrathecal injection warrants mask worn by clinicians during procedure. ISMP Medication Safety Alert! Nurse Advise-ERR. 2010;8(1):1–2.

Inturrisi, C.E. Clinical pharmacology of opioids for pain. The Clinical Journal of Pain. 2002;18(53):S3–S13.

Inturrisi, C.E., Speaking for you: APS Develops and Promulgates REMS Position. APS Bulletin, 2009;19(3). Available at http://www.ampainsoc.org/pub/bulletin/fall09/pres.htm. [Accessed March 16, 2010].

Iocolano, C.F. Perioperative pain management in the chemically dependent patient. Journal of Perianesthesia Nursing. 2000;155(5):329–347.

Ionescu, D., Badescu, C., Acalovschi, I. Nicotine patch for the prevention of postoperative nausea and vomiting. Clinical Drug Investigation. 2007;27(8):559–564.

Ishiyama, T., Iijima, T., Sugawara, T., et al. The use of patient-controlled epidural fentanyl in elderly patients. Anaesthesia. 2007;62(2):1246–1250.

Isono, S., Tanaka, A., Nishino, T. Lateral position decreases collapsibility of the passive pharynx in patients with obstructive sleep apnea. Anesthesiology. 2002;97(4):771–773.

Jackson, K., Ashby, M., Keech, J. Pilot dose finding study of intranasal sufentanil for breakthrough and incident cancer-associated pain. Journal of Pain and Symptom Management. 2002;23(6):450–452.

Jacobi, J., Fraser, G., Coursin, D., et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Critical Care Medicine. 2002;30(1):119–141.

Jacobsen, R., Sjogren, P., Moldrup, C., et al. Physician-related barriers to cancer pain management with opioid analgesics: A systematic review. Journal of Opioid Manage. 2007;5(4):207–214.

Jacox, A., Carr, D.B., Payne, R., et al. No. 9 AHCPR publication No.94-0592. Management of cancer. Clinical practice guideline. Rockville, MD; Agency for Health Care Policy and Research, U.S. Department of Health and Human Services, Public Health Service; 1994.

Jamison, R.N., Schein, J.R., Vallow, S., et al. Neuropsychological effects of long-term opioid use in chronic pain patients. Journal of Pain and Symptom Management. 2003;26(4):913–921.

Janssen. Duragesic® (fentanyl transdermal CII system) prescribing information. Titusville, NJ: Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc, 2008.

Jenkins, H.H., Spencer, E.D., Weissgerber, A.J., et al. Correlating an 11-point verbal nscale to a 4-point verbal rating scale in the measurement of pruritus. Journal of Perianesthesia Nursing. 2009;24(3):152–155.

Jennings, A.L., Davies, A.N., Higgins, J.P.T., et al. Opioids for palliation of breathlessness in terminal illness. Cochrane Database of Systematic Reviews. (3):2001. [CD002066. DOI:10.1002/14651858.CD002066].

Johnson, F., Sun, S., Stauffer, J., et al. Morphine release profile in a formulation containing polymer-coated extended-release morphine sulfate plus sequestered naltrexone. The Journal of Pain. 2007;8(4):S40.

Johnson, F., Wagner, G., Sun, S., et al. Effect of concomitant ingestion of alcohol on the in vivo pharmacokinetics of Kadian (morphine sulfate extended-release) capsules. The Journal of Pain. 2008;9(4):330–336.

Johnson, K.B., Swenson, J.D., Egan, T.D., et al. Midazolam and remifentanil by bolus injection for intensely stimulating procedures of brief duration: Experience with awake laryngoscopy. Anesthesia and Analgesia. 2002;94(5):1241–1243.

Johnson, R.E., Fudala, P.J., Payne, R. Buprenorphine: Considerations for pain management. Journal of Pain and Symptom Management. 2005;29(3):297–326.

Johnson, R.E., Strain, E.C., Amass, L. Buprenorphine: How to use it right. Drug and Alcohol Dependence. 2003;70(Suppl. 2):S59–S77.

Johnson, S.J., Opioid safety in patients with renal or hepatic dysfunction. Pain Treatment Topics 2007 www.pain-topics.org [Accessed February 2, 2009].

Joint Commission, The (TJC). Sentinel event alert: Patient-controlled analgesia by proxy, 2004. http://www.jointcommission.org/SentinelEvents/SentinelEventAlert/sea_33.htm [Accessed January 9, 2005].

Jokela, R.M., Cakmakkaya, O.S., Danzeisen, O., et al. Ondansetron has similar clinical efficacy against both nausea and vomiting. Anaesthesia. 2009;64(2):147–151.

Joly, V., Richebe, P., Guignard, B., et al. Remifentanil-induced postoperative hyperalgesia preventions with small dose ketamine. Anesthesiology. 2005;103(1):147–155.

Jones, H.E., O’Grady, K., Johnson, R., et al. Management of acute postpartum pain in patients maintained on methadone or buprenorphine during pregnancy. The American Journal of Drug and Alcohol Abuse. 2009;35(3):151–156.

Jones, J.B., Johnson, F., Wagner, G., et al. Evaluation of abuse potential of ALO-01, an extended-release morphine sulfate plus sequestered naltrexone formulation, among recreational opioid users. The Journal of Pain. 2008;9(4, Suppl. 1):P34.

Jones, L. Patient-controlled oral analgesia. Orthopaedic Nursing/National Association of Orthopaedic Nurses. 1987;6(1):38–41.

Joo, H.S., Perks, W.J., Kataoka, M.T., et al. A comparison of patient-controlled sedation using either remifentanil or remifentanil-propofol for shock wave lithotripsy. Anesthesia and Analgesia. 2001;93(5):1227–1232.

Jorgensen, H., Fomsgaard, J.S., Dirks, J., et al. Effect of continuous epidural 0.2% ropivacaine vs 0.2% bupivacaine on postoperative pain, motor block and gastrointestinal function after abdominal hysterectomy. British Journal of Anaesthesia. 2000;84(2):144–150.

Jorgensen, H., Wetterslev, J., Moiniche, S., et al. Epidural local anaesthetics versus opioid-based analgesic regimens for postoperative gastrointestinal paralysis, PONV and pain after abdominal surgery. Cochrane Database of Systematic Reviews (Online). (4):2001. [CD001893].

Joyce, M., McSweeney, M., Carrieri-Kohlman, V.L., et al. The use of nebulized opioids in the management of dyspnea: Evidence synthesis. Oncology Nursing Forum. 2004;31(3):551–559.

Juan, G., Ramon, M., Valia, J.C., et al. Palliative treatment of dyspnea with epidural methadone in advanced emphysema. Chest. 2005;128(5):3322–3328.

Kabon, B., Fleischmann, E., Treschan, T., et al. Thoracic epidural anesthesia increases tissue oxygenation during major abdominal surgery. Anesthesia and Analgesia. 2003;97(6):1812–1817.

Kaestli, L.Z., Wasilewski-Rasca, A.F., Bonnabry, P., et al. Use of transdermal drug formulations in the elderly. Drugs and Aging. 2008;25(4):269–280.

Kahl, L., Parvizi, J., Viscusi, E.R., et al. Lessons learned with extended-release epidural morphine after total hip arthroplasty. Clinical Orthopaedics and Related Research. 2010. [in press. 10.1007/s11999-009-1181-3].

Kaiko, R.F., Foley, K.M., Grabinski, P.Y., et al. Central nervous system excitatory effects of meperidine in cancer patients. Annals of Neurology. 1983;13:180–185.

Kalso, E. Oxycodone. Journal of Pain and Symptom Management. 2005;29(Suppl 5):S47–S56.

Kalso, E. How different is oxycodone from morphine? Pain. 2007;132(3):227–228.

Kalso, E., Simpson, K.H., Slappendel, R., et al. Predicting long-term response to strong opioids in patients with low back pain: Findings from a randomized, controlled trial of transdermal fentanyl and morphine. BMC Medicine. 2007;5:39.

Kamal-Bahl, S.J., Stuart, B.C., Beers, M.H. Propoxyphene use and risk for hip fractures in older adults. The American Journal of Geriatric Pharmacotherapy. 2006;4(3):219–226.

Kampe, S., Warm, M., Kaufmann, J., et al. Clinical efficacy of controlled-release oxycodone 20 mg administered on a 12-h dosing schedule on the management of postoperative pain after breast surgery for cancer. Curr Res Opin. 2004;20(2):199–202.

Kanazi, G.E., Aouad, M.T., Jabbour-Khoury, S.L., et al. Effect of low-dose dexmedetomidine or clinidine on the characterstics of bupivacaine spinal block. Acta Anaesthesiologica Scandinavica. 2006;50(2):222–227.

Kaplan, R., Slywka, J., Slagle, S., et al. A titrated morphine analgesic regimen comparing substance users and non-users with AIDS-related pain. Journal of Pain and Symptom Management. 2000;19(4):265–273.

Kastanias, P., Snaith, K.E., Robinson, S. Patient-controlled oral analgesia: A low-tech solution in a high-tech world. Pain Management Nursing. 2006;7(3):126–132.

Katz, J. Pain begets pain. Predictors of long-term phantom limb pain and post-thoracotomy pain. Pain Forum. 1997;6(2):140–144.

Katz, J., Buis, T., Cohen, L. Locked out and still knocking: Predictors of excessive demands for postoperative intravenous patient-controlled analgesia. Canadian Journal of Anesthesia. 2008;55(2):88–99.

Katz, N., Mazer, N.A. The impact of opioids on the endocrine system. The Clinical Journal of Pain. 2009;25(2):170–175.

Katz, N., Rauck, R., Ahdieh, H., et al. A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain. Current Medical Research and Opinion. 2007;23(1):117–128.

Katz, N., Sun, S., Fox, L., et al. Efficacy and safety evaluation of an extended-release morphine sulfate formulation with sequestered naltrexone for the treatment of osteoarthritis. The Journal of Pain. 2008;9(4, Suppl. 1):P41.

Katz, N., Sun, S., Johnson, F., et al. ALO-01 (morphine sulfate and naltrexone hydrochloride) extended-release capsules in the treatment of chronic pain of osteoarthritis of the hip or knee: Pharmacokinetics, efficacy, and safety. The Journal of Pain. 2009. [doi: 10.1016/j.jpain.2009.07.017].

Katz, N.P., Adams, E.H., Chilcoat, H., et al. Challenges in the development of prescription opioid abuse-detrrent formulation. The Clinical Journal of Pain. 2007;23(8):648–660.

Kaya, M., Sariyildiz, O., Karakus, D., et al. Tramadol versus meperidine in the treatment of shivering during spinal anaesthesia. European Journal of Anaesthesiology. 2003;20(4):332–333.

Kaya, T., Buyukkocak, U., Basar, H., et al. Comparison of epidural ropivacaine 0.2% and ropivacaine 0.2% in combination with sufentanil 0.75 microg mL-1 for postcaesarean analgesia. Agri: The Journal of the Turkish Society of Algology. 2008;20(4):30–37.

Kazemi-Kjellberg, F., Henzi, I., Tramer, M.R. Treatment of established postoperative nausea and vomiting: A quantitative systematic review. BMC Anesthesiology. 2001;1(1):2.

Kedlaya, D., Reynolds, L., Waldman, S. Epidural and intrathecal analgesia for cancer pain. Best Practice & Research. Clinical Anaesthesiology. 2002;16(4):651–665.

Keen, M.F. Comparison of intramuscular injection techniques to reduce site discomfort and lesions. Nursing Research. 1986;35:207–210.

Kehlet, H. Preventive measures to minimize or avoid postoperative ileus. Sem Colon Rec Surg. 2005;16(4):203–206.

Kehlet, H., Dahl, J. Epidural analgesia and postoperative outcome? Anesthesiology. 2002;97(4):1025–1026.

Kehlet, H., Holte, K. Review of postoperative ileus. American Journal of Surgery. 2001;182(Suppl. 5A):3S–10S.

Kehlet, H., Jensen, T.S., Woolf, C.J. Persistent postsurgical pain: Risk factors and prevention. Lancet. 2006;367(9522):1618–1625.

Kehlet, H., Wilmore, D.W. Evidence-based surgical care and the evolution of fast-track surgery. Annals of Surgery. 2008;248(2):189–198.

Keita, H., Diouf, E., Tubach, F., et al. Predictive factors of early postoperative urinary retention in the postanesthesia care unit. Anesthesia and Analgesia. 2005;101(2):592–596.

Keita, H., Tubach, F., Maalouli, J., et al. Age-adapted morphine titration produces equivalent analgesia and adverse effects in younger and older patients. European Journal of Anaesthesiology. 2008;25(5):352–356.

Kelly, D.J., Ahmad, M., Brull, S.J. Preemptive analgesia II: Recent advances and current trends. Canadian Journal of Anesthesia. 2001;48(11):1091–1101.

Kent, C.D., Kaufman, B.S., Lowry, J. Dexmedetomidine facilitates the withdrawal of ventilatory support in palliative care. Anesthesiology. 2005;103(2):439–441.

Kerger, K.H., Mascha, E., Steinbrecher, B., et al. Routine use of nasogastric tubes does not reduce postoperative nausea and vomiting. Anesthesia and Analgesia. 2009;109(3):769–773.

Kerr, D., Kelly, A.M., Dietze, P., et al. Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of heroin overdose. Addiction (Abingdon, England). 2009;104(12):2067–2074.

Kerr, I.G., Sone, M., DeAngelis, C., et al. Continuous narcotic infusion with patient-controlled analgesia for chronic cancer pain in outpatients. Annals of Internal Medicine. 1988;108(4):554–557.

Kessler, P., Neidhart, G., Bremerich, D.H., et al. High thoracic epidural anesthesia for coronary artery bypass grafting using two different surgical approaches in conscious patients. Anesthesia and Analgesia. 2002;95(4):791–797.

Kharasch, E.D., Hoffer, C., Whittington, D. Influence of age on the pharmacokinetics and pharmacodynamics of oral transmucosal fentanyl citrate. Anesthesiology. 2004;101(3):738–743.

Kim, S.Y., Kim, E.M., Nam, K.H., et al. Postoperative intravenous patient-controlled analgesia in thyroid surgery: Comparison of fentanyl and ondansetron regimens with and without the nonsteroidal anti-inflammatory drug ketorolac. Thyroid. 2008;18(12):1285–1290.

King Pharmaceuticals Avinza prescribing information. Bristol, TN: King Pharmaceuticals; 2008 Available at http://www.kingpharm.com/kingpharm/uploads/pdf_inserts/AVINZA_PI.pdf [Accessed April 17, 2008].

King Pharmaceuticals King provides additional information on the REMOXY® NDA resubmission plan. Bristol, TN: King Pharmaceuticals; 2008 Available at http://www.kingpharm.com/Investors/News_Details.cfm?news_item_id=522 [Accessed July 16, 2009].

King Pharmaceuticals Embeda prescribing information. Bristol, TN: King Pharmaceuticals; 2009. http://www.embeda.com/ [Accessed August 16, 2009].

Kivitz, A., Ma, C., Ahdieh, H., et al. A 2-week multicenter, randomized, double blind, placebo-controlled dose ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee. Clinical Therapeutics. 2006;3(28):352–364.

Kizilkaya, M., Yildirim, O.S., Dogan, N., et al. Analgesic effects of intraarticular sufentanil and sufentanil plus methylprednisolone after arthroscopic knee surgery. Anesthesia and Analgesia. 2004;98(4):1062–1965.

Kleinert, R., Lange, C., Steup, A., et al. Single dose analgesic efficacy of tapentadol in postsurgical dental pain: The results of a randomized, double-blind, placebo-controlled study. Anesthesia and Analgesia. 2008;107(6):2048–2055.

Klepstad, P., Kaasa, S., Jystad, A., et al. Immediate- or sustained-release morphine for dose finding during start of morphine to cancer patients: A randomized, double-blind trial. Pain. 2003;101(1–2):193–198.

Klepstad, P., Kaasa, S., Skauge, M., et al. Pain intensity and side effects during titration of morphine to cancer patients using a fixed schedule dose escalation. Acta Anaesthesiologica Scandinavica. 2000;44(6):656–664.

Kneip, C., Terlinden, R., Beier, H., et al. Investigations into the drug-drug interaction potential of tapentadol in human liver microsomes and fresh human hepatocytes. Drug Metab Lett. 2008;2(1):67–75.

Knotkova, H., Fine, P.G., Portenoy, R.K. Opioid rotation: The science and limitations of the equianalgesic dose table. Journal of Pain and Symptom Management. 2009;38(3):426–439.

Ko, W.M., Ferrante, F.M. New onset lumbar radicular pain after implantation of an intrathecal drug delivery system: Imaging catheter migration. Regional Anesthesia and Pain Medicine. 2006;31(4):363–367.

Kolesnikov, Y.A., Wilson, R.S., Pasternak, G.W. The synergistic analgesic interactions between hydrocodone and ibuprofen. Anesthesia and Analgesia. 2003;97(6):1721–1723.

Koo, H.C., Moon, J.H., Choi, H.J., et al. Effect of transdermal fentanyl patch on sphincter of Oddi—For application of pain management in pancreatitis. (Abstract). Gastrointestinal Endoscopy. 2009;69(5):AB270.

Kopka, A., Wallace, E., Reilly, G., et al. Observational study of perioperative Ptc_cO2 and SpO2 in non-ventilated patients receiving epidural infusion or patient-controlled analgesia using a single earlobe monitor (TOSCA). British Journal of Anaesthesia. 2007;99(4):567–571.

Kornick, C.A., Santiago-Palma, J., Moryl, N., et al. Benefit-risk assessment of transdermal fentanyl for treatment of chronic pain. Drug safety: an International Journal of Medical Toxicology and Drug Experience. 2003;26(13):951–973.

Kornick, C.A., Santiago-Palma, J., Schulman, G., et al. A safe and effective method for converting patients from transdermal to intravenous fentanyl for treatment of acute cancer-related pain. Cancer. 2003;97(12):3121–3124.

Kornitzer, B.S., Manace, L.C., Fischberg, D.J., et al. Prevalence of meperidine use in older surgical patients. Archives of Surgery. 2006;141(8):76–81.

Kothari, S.N., Boyd, W.C., Bottcher, M.L., et al. Antiemetic efficacy of prophylactic dimenhydrinate (Dramamine) vs ondansetron (Zofran). Surgical Endoscopy. 2000;14(10):926–929.

Kraft, M.D. Emerging pharmacologic options for treating postoperative ileus. American Journal of Health-System Pharmacy. 2007;64(20):S13–S20.

Kranke, P., Eberhart, L.H., Roewer, N., et al. Single-dose parenteral pharmacological interventions for prevention of postoperative shivering: A quantitative systematic review of randomized controlled trials. Anesthesia and Analgesia. 2004;99(3):718–727.

Kranke, P., Morin, A.M., Roewer, N., et al. The efficacy and safety of transdermal scopolamine for the prevention of postoperative nausea and vomiting: A quantitative systematic review. Anesthesia and Analgesia. 2002;95(1):133–143.

Krantz, M.J., Martin, J., Stimmel, B., et al. QTc interval screening in methadone treatment. Annals of Internal Medicine. 2009;150(6):387–395.

Krenzischek, D., Wilson, L. Introduction to the ASPAN pain and comfort clinical practice guideline. Journal of Perianesthesia Nursing. 2003;18(4):228–231.

Kress, H.G., Von der Laage, D., Hoerauf, K.H., et al. A randomized, open, parallel group, multicenter trial to investigate analgesic efficacy and safety of the new transdermal fentanyl patch compared to standard opioid treatment in cancer pain. Journal of Pain and Symptom Management. 2008;36(3):268–279.

Kshatri, A.M., Foster, P.A. Adrenocorticotropic hormone infusion as a novel treatment for postdural puncture headache. Regional Anesthesia. 1997;22(5):432–434.

Kumar, K., Bodani, V., Bishop, S., et al. Use of intrathecal bupivacaine in refractory chronic nonmalignant pain. Pain Medicine (Malden, Mass.). 2009;10(5):819–828.

Kumar, M.G., Lin, S. Hydromorphone in the management of cancer-related pain: An update on routes of administration and dosage forms. Journal of Pharmacy & Pharmaceutical Sciences. 2007;10(4):504–518.

Kunz, K. Opioid cost factors. Cancer Pain Update. 1994:3. [Fall].

Kurella, M., Bennett, W.M., Chertow, G.M. Analgesia in patients with ESRD: A review of available evidence. American Journal of Kidney Diseases. 2003;42(2):217–228.

Ladak, S.S.J., Katznelson, R., Muscat, M., et al. Incidence of urinary retention in patients with thoracic patient-controlled epidural analgesia (TPCEA) undergoing thoractomy. Pain Management Nursing. 2009;10(2):94–98.

Lagan, G., McLure, H.A. Review of local anaesthetic agents. Curr Anaesth Crit Care. 2004;15(4–5):247–254.

Lahtinen, P., Kokki, H., Hynynen, M. Remifentanil infusion does not induce opioid tolerance after cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia. 2008;22(2):225–229.

Lalley, P.M. D1-dopamine receptor agonists prevent and reverse opiate depression of breathing but not antinociception in the cat. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 2005;289(1):R45–R51.

Lalovic, B., Kharasch, E., Hoffer, C., et al. Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: Role of circulating active metabolites. Clinical Pharmacology and Therapeutics. 2006;79(5):461–479.

Lamb, E., Top 200 prescription drugs of 2007. Pharmacy Times, 2008;74(5):20–23. Available at http://www.pharmacytimes.com/issues/articles/2008-05_003.asp [Accessed June 9, 2008].

Landau, R. One size does not fit all. (Editorial). Anesthesiology. 2006;105(2):235–237.

Langevin, P.B. How should we handle epidural solutions: One view. (Editorial). Regional Anesthesia and Pain Medicine. 2000;25(4):343–346.

Langevin, P.B., Gravenstein, N., Langevin, S.O., et al. Epidural catheter reconnection. Safe and unsafe practice. Anesthesiology. 1996;85(4):883–888.

Langford, R., McKenna, F., Ratcliffe, S., et al. Transdermal fentanyl for improvement of pain and functioning in osteoarthritis: A randomized, placebo-controlled trial. Arthritis and Rheumatism. 2006;54(6):1829–1837.

Larijani, G.E., Goldberg, M.E. Analgesic evaluation in postoperative patients. (Letter). Anesthesiology. 2004;100(3):744–745.

Larijani, G.E., Goldberg, M.E., Gratz, I., et al. Analgesic and hemodynamic effects of a single 7.5 mg intravenous dose of morphine in patients with moderate-to-severe postoperative pain. Pharmacotherapy. 2004;24(12):1675–1680.

Latta, K.S., Ginsberg, B., Barkin, R.L. Meperidine: A critical review. American Journal of Therapeutics. 2002;9(1):53–68.

Lattermann, R., Wykes, L., Eberhart, L., et al. A randomized controlled trial of the anticatabolic effect of epidural analgesia and hypocaloric glucose. Regional Anesthesia and Pain Medicine. 2007;32(3):227–232.

Launay-Vacher, V., Karie, S., Fau, J.B., et al. Treatment of pain in patients with renal insufficiency: The World Health Organization three-step ladder adapted. The Journal of Pain. 2005;6(3):137–148.

Lauretti, G.R., Oliveira, G.M., Pereira, N.L. Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients. British Journal of Cancer. 2003;89(11):2027–2030.

Lavelle, W., Lavelle, E.D., Lavelle, L. Intra-articular injections. The Medical Clinics of North America. 2007;91(2):241–250.

Laverty, D. Treating cancer-related breakthrough pain: The oral transmucosal route. International Journal of Palliative Nursing. 2007;13(7):326–331.

Lawlor, P., Turner, K., Hanson, J., et al. Dose ratio between morphine and hydromorphone in patients with cancer pain: A retrospective study. Pain. 1997;72(1–2):79–85.

Lawlor, P.G., Turner, K.S., Hanson, J., et al. Dose ratio between morphine and methadone in patients with cancer pain: A retrospective study. Cancer. 1998;82(6):1167–1173.

Leavitt, S.B. Methadone-drug interactions. 3rd ed. Addiction Treatment Forum; 2005. Available at http://www.atforum.com/SiteRoot/pages/addiction_resources/Drug_Interactions.pdf [Accessed June 8, 2008].

Leavitt, S.B., Methadone-drug interactions. Pain Treatment Topics 2006. Available at http://pain-topics.org/pdf/Methadone-Drug_Intx_2006.pdf [Accessed July 31, 2009].

Leavitt, S.B., Methadone safety handout for patients. Pain Treatment Topics 2008. Available at http://pain-topics.org/pdf/MethadoneHandout.pdf [Accessed July 31, 2009].

Leavitt, S.B. Misguided pain guidelines? When strong claims follow from weak evidence. Pain Treatment Topics e-Briefing. 2009;4(1):1–8.

LeBon, B., Zeppetella, G., Higginson, I.J., et al. Effectiveness of topical administration of opioids in palliative care: A systematic review. Journal of Pain and Symptom Management. 2009;37(5):913–917.

Lee, A., Done, M.L. The use of nonpharmacologic techniques to prevent postoperative nausea and vomiting: A meta-analysis. Anesthesia and Analgesia. 1999;88(6):1362–1369.

Lee, A., Fan, L.T.Y. Stimulation of the wrist acupuncture point P6 for preventing postoperative nausea and vomiting. Cochrane Database of Systematic Reviews (Online). (2):2009. [CD003281].

Lee, E.Y., Lee, E.B., Park, B.J., et al. Tramadol 37.5-  mg/acetaminophen 325-  mg combination tablets added to regular therapy for rheumatoid arthritis pain: A 1-week, randomized, double-blind, placebo-controlled trial. Clinical Therapeutics. 2006;28(12):2052–2060.

Lee, F., Cundiff, D. Meperidine vs morphine in pancreatitis and cholecystitis. (Letter). Archives of Internal Medicine. 1998;158(21):2399.

Lehmann, K.A. Recent developments in patient-controlled analgesia. Journal of Pain and Symptom Management. 2005;29(Suppl. 5):S72–S89.

Lehne, R.A. Pharmacology for Nursing Care, 5th ed. St. Louis: Saunders, 2004.

Lehr, V.T., BeVier, P. Patient-controlled analgesia for the pediatric patient. Orthopaedic Nursing/National Association of Orthopaedic Nurses. 2003;22(4):298–304.

Lemberg, K.K., Siiskonen, A.O., Kontinen, V.K., et al. Pharmacological characterization of noroxymorphone as a new opioid for spinal analgesia. Anesthesia and Analgesia. 2008;106(2):463–470.

Lennernas, B., Hedner, T., Holmberg, M., et al. Pharmacokinetics and tolerability of different doses of fentanyl following sublingual administration of a rapidly dissolving tablet to cancer patients: A new approach to treatment of incident pain. British Journal of Clinical Pharmacology. 2005;59(2):249–253.

Lentschener, C., Tostivint, P., White, P.F., et al. Opioid-induced sedation in the postanesthesia care unit does not insure adequate pain relief: A case-control study. Anesthesia and Analgesia. 2007;105(4):1143–1147.

Lenz, H., Sandvik, L., Qvigstad, E., et al. A comparison of intravenous oxycodone and intravenous morphine in patient-controlled postoperative analgesia after laparoscopic hysterectomy. Anesthesia and Analgesia. 2009;109(4):1279–1283.

Leone, M., Albanese, J., Viviand, X., et al. The effects of remifentanil on endotracheal suction-induced increases in intracranial pressure in head-injured patients. Anesthesia and Analgesia. 2004;99(4):1193–1198.

Leppert, W. The role of methadone in cancer pain treatment—A review. International Journal of Clinical Practice. 2009;63(7):1095–1109.

Leppert, W., Łuczak, J. The role of tramadol in cancer pain treatment—A review. Supportive Care in Cancer. 2005;13(1):5–17.

Leslie, J.B. Alvimopan for the management of postoperative ileus. The Annals of Pharmacotherapy. 2005;39(9):1502–1510.

Levy, M.H. Integration of pain management into comprehensive cancer care. Cancer. 1989;63(11 suppl):2328–2335.

Levy, M.H. Medical management of cancer pain. In: Warfield C., ed. Principles and practice of pain management. New York: McGraw-Hill; 1993:235–250.

Lew, E., Yeo, S.W., Thomas, E. Combined spinal-epidural anesthesia using epidural volume extension leads to faster motor recovery after elective cesarean delivery: A prospective, randomized, double-blind study. Anesthesia and Analgesia. 2004;98(3):810–814.

Li Wan Po, A., Zhang, W.Y. Systematic overview of co-proxamol to assess analgesic effects of addition of dextropropoxyphene to paracetamol. BMJ (Clinical Research Ed.). 1997;315(7122):1565–1571.

Likar, R., Vadlau, E.M., Breschan, C., et al. Comparable analgesic efficacy of transdermal buprenorphine in patients over and under 65 years of age. The Clinical Journal of Pain. 2008;25(6):536–543.

Likar, R., Wittels, M., Molnar, M., et al. Pharmacokinetic and pharmacodynamic properties of tramadol IR and SR in elderly patients: A prospective, age-group-controlled study. Clinical Therapeutics. 2006;28(12):2022–2039.

Lilker, S., Rofaeel, A., Balki, M., et al. Comparison of fentanyl and sufentanil as adjuncts to bupivacaine for labor epidural analgesia. Journal of Clinical Anesthesia. 2009;21(2):108–112.

Lim, S., Prasad, M., Samuels, P., et al. High-dose methadone in pregnant women and its effect on duration of neonatal abstinence syndrome. American Journal of Obstetrics and Gynecology. 2009;200(1):70.e1–70.e5.

Lim, Y., Wilson, S., Katz, S. A comparison of patient-controlled epidural pethidine vs. nurse-administered epidural pethidine for analgesia after caesarean section. Journal of Opioid Management. 2006;2(2):99–104.

Litman, R.S. Conscious sedation with remifentanil during painful medical procedures. Journal of Pain and Symptom Management. 2000;19(6):468–471.

Little, B.B., Snell, L.M., Van Beveren, T.T., et al. Treatment of substance abuse during pregnancy and infant outcome. American Journal of Perinatology. 2003;20(5):255–262.

Liu, G.G., Christensen, D.B. The continuing challenge of inappropriate prescribing in the elderly: An update of the evidence. Journal of the American Pharmaceutical Association. 2002;42(6):847–857.

Liu, L.L., Gropper, M.A. Postoperative analgesia and sedation in the adult intensive care unit: A guide to drug selection. Drugs. 2003;63(8):755–767.

Liu, M., Wittbrodt, E. Low-dose oral naloxoen reverses opioid-induced constipation and analgesia. Journal of Pain and Symptom Management. 2002;23(1):48–53.

Liu, S.S., Carpenter, R.L., Mulroy, M.F., et al. Intravenous versus epidural administration of hydromorphone. Anesthesiology. 1995;82(3):682–688.

Liu, S.S., Moore, J.M., Luo, A.M., et al. Comparison of three solutions of ropivacaine/fentanyl for postoperative patient-controlled epidural analgesia. Anesthesiology. 1999;90(3):727–733.

Liu, S.S., Wu, C.L. The effect of analgesic technique on postoperative patient-reported outcomes including analgesia: A systematic review. Anesthesia and Analgesia. 2007;105(3):789–808.

Liu, S.S., Wu, C.L. Effect of postoperative analgesia on major postoperative complications: A systematic update of the evidence. Anesthesia and Analgesia. 2007;104(3):689–702.

Locniskar, A., Greenblatt, D.J., Zinny, M.A. Pharmacokinetics of dezocine, a new analgesic: Effect of dose and route of administration. European Journal of Clinical Pharmacology. 1986;30(1):121–123.

Locsin, R.G. Pinch-grasp technique. PRN Forum. 1985;4:4–5.

Lorenz, J., Beck, H., Bromm, B. Cognitive performance, mood and experimental pain before and during morphine-induced analgesia in patients with chronic non-malignant pain. Pain. 1997;73(3):369–375.

Lotsch, J. Opioid metabolites. Journal of Pain and Symptom Management. 2005;29(Suppl. 5):S10–S24.

Lotsch, J., Dudziak, R., Freynhagen, R., et al. Fatal respiratory depression after multiple morphine injections. Clin Pharmacokinet. 2006;45(11):1051–1060.

Lovovschi, V., Aubrun, F., Bonnet, P., et al. Intravenous morphine titration to treat severe pain in the ED. The American Journal of Emergency Medicine. 2008;26(4):676–682.

Lucas, C.E., Vlahos, A.L., Ledgerwood, A.M. Kindness kills: The negative impact of pain as the fifth vital sign. Journal of the American College of Surgeons. 2007;205(1):101–107.

Lugo, R.A., Kern, S.E. The pharmacokinetics of oxycodone. Journal of Pain & Palliative Care Pharmacotherapy. 2004;18(4):17–30.

Lugo, R.A., Satterfield, K.L., Kern, S.E. Pharmacokinetics of methadone. Journal of Pain & Palliative Care Pharmacotherapy. 2005;19(4):13–24.

Lynch, M.E. A review of the use of methadone for the treatment of chronic noncancer pain. Pain Research & Management. 2005;10(3):133–144.

Lynn, J., Teno, J.M., Phillips, R.S. Perceptions by family members of the dying experience of older and seriously ill patients. Annals of Internal Medicine. 1997;126(2):97–106.

Ma, K., Jiang, W., Zhou, Q., et al. The efficacy of oxycodone for management of acute pain episodes in chronic neck pain patients. International Journal of Clinical Practice. 2008;62(2):241–247.

Maalouf, D.B., Liu, S.S. Clinical application of epidural analgesia. In: Sinatra R.S., de Leon-Casasola O.A., Ginsberg B., Viscusi E.R., eds. Acute pain management. Cambridge, New York: Cambridge University Press; 2009:221–229.

Macario, A. Systematic literature review of the economics of intravenous patient-controlled analgesia. P, T. 2005;30(7):392–399.

Machelska, H. Targeting of opioid-producing leukocytes for pain control. Neuropeptides. 2007;41(6):355–363.

MacIntyre, P.A., Margetts, L., Larsen, D., et al. Oral transmucosal fentanyl citrate versus placebo for painful dressing changes: A crossover trial. Journal of Wound Care. 2007;16(3):118–121.

Macintyre, P.E., Coldrey, J. Patient-controlled analgesia. In: Macintyre P.E., Walker S.M., Rowbotham D.J., eds. Acute pain. 2nd ed. London: UK, Hodder Arnold; 2008:217–235.

Macintyre, P.E., Coldrey, J. Intravenous patient-controlled analgesia. In: Sinatra R.S., de Leon-Casasola O.A., Ginsberg B., Viscusi E.R., eds. Acute pain management. Cambridge, New York: Cambridge University Press; 2009:204–220.

Madacsy, L., Bertalan, V., Szepes, A., et al. Effect of nalbuphine on the motility of the sphincter of Oddi in patients with suspected sphincter of Oddi dysfunction. Gastrointestinal Endoscopy. 2003;57(3):319–323.

Maddux, J.F., Williams, T.R., Ziegler, J.A. Driving records before and during methadone maintenance. The American Journal of Drug and Alcohol Abuse. 1977;4(1):91–100.

Maier, C., Hildebrandt, J., Klinger, R., et al. Morphine responsiveness, efficacy and tolerability in patients with chronic non-tumor associated pain – results of a double-blind placebo-controlled trial (MONTAS). Pain. 2002;97(3):223–233.

Makin, M.K. Subcutaneous methadone in terminally-ill patients. Journal of Pain and Symptom Management. 2000;19(4):237–238.

Malkin, J.D., Ackerman, S.J., Schein, J.R., et al. Outcomes associated with fentanyl transdermal system and oxycodone controlled-release in a California Medicaid population. Pain Medicine (Malden, Mass.). 2001;2(3):246–247.

Malloy, P., Paice, J., Virani, R., et al. End-of-Life Nursing Education Consortium: 5 years of educating graduate nursing faculty in excellent palliative care. Journal of Professional Nursing. 2008;24(6):352–357.

Maloney, C.M., Kesner, R.K., Klein, G., et al. The rectal administration of MS Contin: Clinical implications of use in end stage cancer. The American Journal of Hospice Care. 1989;6(4):34–35.

Maltoni, M., Pittureri, C., Scarpi, E., et al. Palliative sedation does not hasten death: Results from a prospective multicenter study. Annals of Oncology. 2009;20(7):1163–1169.

Maltoni, M., Scarpi, E., Modonesi, C., et al. A validation study of the WHO analgesic ladder: A two-step vs three-step strategy. Supportive Care in Cancer. 2005;13(11):888–894.

Manfredi, P.L., Houde, R.W. Prescribing methadone, a unique analgesic. The Journal of Supportive Oncology. 2003;1(3):216–220.

Manfredi, P.L., Ribeiro, S., Chandler, S.W. Inappropriate use of naloxone in cancer patients with pain. Journal of Pain and Symptom Management. 1996;11(2):131–134.

Mann, C., Pouzeratte, Y., Boccara, G., et al. Comparison of intravenous or epidural patient-controlled analgesia in the elderly after major abdominal surgery. Anesthesiology. 2000;92(2):433–441.

Mannino, R., Coyne, P., Swainey, C., et al. Methadone for cancer-related neuropathic pain: A review of the literature. Journal of Opioid Management. 2006;2(5):269–276.

Manworren, R.C.B. A call to action to protect range orders. The American Journal of Nursing. 2006;106(7):30–33.

Marcantonio, E.R., Juarez, G., Goldman, L., et al. The relationship of postoperative delirium with psychoactive medications. JAMA: The Journal of the American Medical Association. 1994;272(19):1518–1522.

Marcou, T.A., Marque, S., Mazoit, J.X., et al. The median effective dose of tramadol and morphine for postoperative patients: A study of interactions. Anesthesia and Analgesia. 2005;100(2):469–474.

Marier, J.F., Lor, M., Morin, J., et al. Comparative bioequivalence study between a novel natrix transdermal delivery system of fentanyl and a commercially available reservoir formulation. British Journal of Clinical Pharmacology. 2006;63(1):121–124.

Marier, J.F., Lor, M., Potvin, D., et al. Pharmacokinetics, tolerability, and performance of a novel matrix transdermal delivery system of fentanyl relative to the commercially available reservoir formulation in healthy subjects. Journal of Clinical Pharmacology. 2006;46(6):642–653.

Marinangeli, F., Ciccozzi, A., Aloisio, L., et al. Improved cancer pain treatment using combined fentanyl-TTS and tramadol. Pain Practice. 2007;7(4):307–312.

Marinangeli, F., Ciccozzi, A., Leonardis, M., et al. Use of strong opioids in advanced cancer pain: A randomized trial. Journal of Pain and Symptom Management. 2004;27(5):409–416.

Marquardt, K.A., Alsop, J.A., Albertson, T.E. Tramadol exposures reported to statewide poison control system. The Annals of Pharmacotherapy. 2005;39(6):1039–1044.

Marret, E., Kurdi, O., Zufferey, P., et al. Effects of nonsteroidal antiinflammatory drugs on patient-controlled analgesia morphine side effects. Anesthesiology. 2005;102(6):1249–1260.

Martinez, J.B., Moos, D.D., Dahlen, L.L. Droperidol’s effect on QT interval. Journal of Perianesthesia Nursing. 2006;21(1):82–87.

Mathew, P., Storey, P. Subcutaneous methadone in terminally ill patients: Manageable local toxicity. Journal of Pain and Symptom Management. 1999;18(1):49–52.

Mathieu, N., Cnudde, N., Engelman, E., et al. Intranasal sufentanil is effective for postoperative analgesia in adults. Canadian Journal of Anesthesia. 2006;53(1):60–66.

Matot, I., Drenger, B., Weissman, C., et al. Epidural clonidine, bupivacaine and methadone as the sole agent after thoractomy for lung resection. Anaesthesia. 2004;59(9):861–866.

Matot, I., Scheinin, O., Eid, A., et al. Epidural anesthesia and analgesia in liver resection. Anesthesia and Analgesia. 2002;95(5):1179–1181.

Matsumoto, A.K., Babul, N., Ahdieh, H. Oxymorphone extended-release tablets relieve moderate to severe pain and improve physical function in osteoarthritis: Results of a randomized, double-blind, placebo- and active-controlled phase III trial. Pain Medicine (Malden, Mass.). 2005;6(5):357–366.

May, J.A., White, H.C., Leonard-White, A., et al. The patient recovering from alcohol or drug addiction: Special issues for the anesthesiologist. Anesthesia and Analgesia. 2001;92(6):1601–1608.

Mayer, J., Boldt, J., Schellhaafs, A., et al. Bispectral index-guided general anesthesia in combination with thoracic epidural analgesia reduces recovery time in fast-track colon surgery. Anesthesia and Analgesia. 2007;104(5):1145–1149.

Mazzocato, C., Buclin, T., Rapin, C.H. The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: A randomized double-blind controlled trial. Annals of Oncology. 1999;10(12):1511–1514.

McBride, J., Knight, D., Piper, J., et al. Long-term effect of introducing an early warning score on respiratory rate charting on general wards. Resuscitation. 2005;65(1):41–44.

McCaffery, M., Herr, K., & Pasero, C. Assessment: Basic problems, misconceptions, and practical tools. In C. Pasero, & M. McCaffery (Eds.), Pain: Assessment and pharmacologic management (in press). St. Louis: Mosby.

McCaffery, M., Lochman, C. Controlled release morphine products. The American Journal of Nursing. 1996;96(4):65.

McCaffery, M., Martin, L., Ferrell, B.R. Analgesic administration via rectum or stoma. Journal of ET Nursing. 1992;19(4):114–121.

McCaffery, M., Vourakis, C. Assessment and relief of pain in chemically dependent patients. Orthopaedic Nursing/National Association of Orthopaedic Nurses. 1992;11(2):13–27.

McCartney, C.J.L., Niazi, A. Use of opioid analgesics in the perioperative period. In: Shorten G., Carr D.B., Harmon D., Puig M.M., Browne J., eds. Postoperative pain management: An evidence-based guide to practice. Philadelphia: Saunders; 2006:137–147.

McClean, R. Standard IV morphine dose given in the ER may be ineffective. Pain Medicine News. 2005;3(10):5.

McClellan, K., Scott, L.J. Tramadol/paracetamol. Drugs. 2003;63(11):1079–1086.

McGee, J.L., Alexander, M.R. Phenothiazine analgesia: Fact or fantasy? American Journal of Hospital Pharmacy. 1979;36(5):633–640.

McIlwain, H., Ahdieh, H. Safety, tolerability, and effectiveness of oxymorphone extended release for moderate to severe osteoarthritis pain. A one year study. American Journal of Therapeutics. 2005;12(2):105–112.

Mcintyre, P.E., Upton, R. Acute pain management in the elderly patient. In: Macintyre P.E., Walker S.M., Rowbotham D.J., eds. Acute pain. 2nd ed. London: UK, Hodder Arnold; 2008:504–525.

McMillan, S.C., Williams, F.A. Validity and reliability of the Constipation Assessment Scale. Cancer Nursing. 1989;12(3):183–188.

McNicol, E., Boyce, D.B., Schumann, R., et al. Efficacy and safety of mu-opioid antagonists in the treatment of opioid-induced bowel dysfunction: Systematic review and meta-analysis of randomized controlled trials. Pain Medicine (Malden, Mass.). 2008;9(6):634–659.

McNulty, J.P. Can levorphanol be used like methadone for intractable refractory pain? Journal of Palliative Medicine. 2007;10:293–296.

Medical News Today. TheraQuest’s IND for abuse deterrent strong opioid (TQ-1015) accepted by FDA, 2008. http://www.medicalnewstoday.com/articles/129330.php [Accessed September 10, 2009].

Medina, H.J., Gavin, E.M., Dirckx, M., et al. Remifentanil as a single drug for extracorporeal shock wave lithotripsy: A comparison of infusion doses in terms of analgesic potency and side effects. Anesthesia and Analgesia. 2005;101(2):365–370.

Meek, T. Epidural anaesthesia and analgesia in major surgery. Curr Anaesth Crit Care. 2004;15(4–5):239–246.

Mehta, V., Langford, R.M. Acute pain management for opioid dependent patients. Anaesthesia. 2006;61:269–276.

Meissner, W., Leyendecker, P., Mueller-Lissner, S., et al. A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation. European Journal of Pain (London, England). 2009;13(9):56–64.

Meldrum, M. The ladder and the clock: Cancer pain and public policy at the end of the twentieth century. Journal of Pain and Symptom Management. 2005;29(1):41–54.

Melzack, R., Abbott, F.V., Zackon, W., et al. Pain on a surgical ward: A survey of duration and intensity of pain and the effectiveness of medication. Pain. 1987;29(1):67–72.

Mendola, C., Ferrante, D., Oldani, E., et al. Thoracic epidural analgesia in post-thoracotomy patients: Comparison of three different concentrations of levobupivacaine and sufentanil. British Journal of Anaesthesia. 2009;102(3):418–423.

Menefee, L.A., Frank, E.D., Crerand, C., et al. The effects of transdermal fentanyl on driving, cognitive performance, and balance in patients with chronic nonmalignant pain conditions. Pain Medicine (Malden, Mass.). 2004;5(1):42–49.

Menefee, L.A., Katz, N.P., Zacharoff, K.L. PainEDU.org Manual, 3rd ed. Newton, MA: Inflexxion, 2007.

Menigaux, C., Guignard, B., Fletcher, D., et al. More epidural than intravenous sufentanil is required to provide comparable postoperative pain relief. Anesthesia and Analgesia. 2001;93(2):472–476.

Mercadante, S. Dantrolene treatment of opioid-induced myoclonus. Anesthesia and Analgesia. 1995;81(6):1307–1308.

Mercadante, S. Breakthrough (episodic) vs. baseline pain in cancer. Cancer Pain Release. 2006;17(4):1–3.

Mercadante, S. Breakthrough pain in cancer patients. Pain Clinical Updates. IASP. 2006;14(1):1–4.

Mercadante, S., Arcuri, E. Pharmacological management of cancer pain in the elderly. Drugs and Aging. 2007;24(9):761–776.

Mercadante, S., Arcuri, E., Ferrera, P., et al. Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain. Journal of Pain and Symptom Management. 2005;30(5):485–491.

Mercadante, S., Arcuri, E., Fusco, F., et al. Randomized double-blind, double-dummy crossover clinical trial of oral tramadol versus rectal tramadol administration in opioid-naive cancer patients with pain. Supportive Care in Cancer. 2005;13(9):702–707.

Mercadante, S., Bruera, E. Opioid switching: A systematic and critical review. Cancer Treatment Reviews. 2006;32(4):304–315.

Mercadante, S., Casuccio, A., Calderone, L. Rapid switching from morphine to methadone in cancer patients with poor response to morphine. Journal of Clinical Oncology. 1999;17(10):3307–3312.

Mercadante, S., Casuccio, A., Fulfaro, F., et al. Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: A prospective study. Journal of Clinical Oncology. 2001;19(11):2898–3904.

Mercadante, S., Costanzo, B.V., Fusco, F., et al. Breakthrough pain in advanced cancer patients followed at home: A longitudinal study. Journal of Pain and Symptom Management. 2009;38(4):554–560.

Mercadante, S., Ferrera, P., Villari, P., et al. Opioid escalation in patients with cancer pain: The effect of age. Journal of Pain and Symptom Management. 2006;32(5):413–419.

Mercadante, S., Ferrera, P., Villari, P., et al. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit. Journal of Pain and Symptom Management. 2009;37(4):632–641.

Mercadante, S., Intravaia, G., Villari, P., et al. Intravenous morphine for breakthrough (episodic-) pain in an acute palliative care unit: A confirmatory study. Journal of Pain and Symptom Management. 2008;35(3):307–313.

Mercadante, S., Porzio, G., Ferrera, P., et al. Low morphine doses in opioid-naïve cancer patients with pain. Journal of Pain and Symptom Management. 2006;31(3):242–247.

Mercadante, S., Porzio, G., Ferrera, P., et al. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. European Journal of Pain (London, England). 2008;12(8):1040–1046.

Mercadante, S., Radbruch, L., Caraceni, A., et al. Episodic (breakthrough) pain. Cancer. 2002;94(3):832–839.

Mercadante, S., Villari, P. Clinical problems with transdermal titration from 25 mcg to 50 mcg/hr. (Letter). Journal of Pain and Symptom Management. 2001;21(6):448–449.

Mercadante, S., Villari, P., Ferrera, P., et al. Rapid titration with intravenous morphine for severe cancer pain and immediate oral conversion. Cancer. 2002;95(1):203–208.

Mercadante, S., Villari, P., Ferrera, P., et al. Optimization of opioid therapy for preventing incident pain associated with bone metastases. Journal of Pain and Symptom Management. 2004;28(5):505–510.

Mercadante, S., Villari, P., Ferrera, P., et al. Transmucosal fentanyl vs intravenous morphine in doses proportional to basal opioid regimen for episodic-breakthrough pain. British Journal of Cancer. 2007;6(12):1828–1833.

Miaskowski, C. Patient-controlled modalities for acute postoperative pain management. Journal of Perianesthesia Nursing. 2005;20(4):255–267.

Miaskowski, C. A review of the incidence, causes, consequences, and management of gastrointestinal effects associated with postoperative opioid administration. Journal of Perianesthesia Nursing. 2009;24(4):222–228.

Miaskowski, C., Cleary, J., Burney, R., et al. Guideline for the management of cancer pain in adults and children IL. Glenview: American Pain Society, 2005.

Miaskowski, C., Dodd, M.J., West, C., et al. Lack of adherence with the analgesic regimen: A significant barrier to effective cancer pain management. Journal of Clinical Oncology. 2001;19(23):4275–4279.

Miaskowski, C., Mack, K.A., Dodd, M.J., et al. Oncology outpatients with pain from bone metastasis require more than around-the-clock dosing of analgesics to achieve adequate pain control. The Journal of Pain. 2002;3(1):12–20.

Mikkelsen, L.P., Butler, J., Huerta, D., et al. A pharmacokinetic and tolerability evaluation of two continuous subcutaneous infusions systems compared to an oral controlled-release morphine. Journal of Pain and Symptom Management. 2000;19(5):348–356.

Mildh, L.H., Scheinin, H., Kirvelä, O.A. The concentration-effect relationship of the respiratory depressant effects of alfentanil and fentanyl. Anesthesia and Analgesia. 2001;93(4):939–946.

Miller, M.G., McCarthy, N., O’Boyle, C.A., et al. Continuous subcutaneous infusion of morphine vs. hydromorphone: A controlled trial. Journal of Pain and Symptom Management. 1999;18(1):9–16.

Miller, P.L., Ernst, A.A. Sex differences in analgesia: A randomized trial of mu versus kappa opioid agonists. Southern Medical Journal. 2004;97(1):35–41.

Milligan, K., Lanteri-Minet, M., Borchert, K., et al. Evaluation of long-term efficacy and safety of transdermal fentanyl in the treatment of chronic noncancer pain. The Journal of Pain. 2001;2(4):197–204.

Minozzi, S., Amato, L., Vecchi, S., et al. Maintenance agonist treatments for opiate dependent pregnant women. Cochrane Database of Systematic Reviews (Online). (2):2008. [CD006318].

Mishra, S., Bhatnagar, S., Gupta, D., et al. Incidence and management of phantom limb pain according to World Health Organization analgesic ladder in amputees of malignant origin. The American Journal of Hospice & Palliative Care. 2008;24(6):455–462.

Mitchell, A., van Zanten, S.V., Inglis, K., et al. A randomized controlled trial comparing acetaminophen plus ibuprofen versus acetaminophen plus codeine plus caffeine after outpatient general surgery. Journal of the American College of Surgeons. 2008;206(3):472–479.

Mitra, S. Opioid-induced hyperalgesia: Pathophysiology and clinical implications. Journal of Opioid Management. 2008;4(3):123–130.

Mitra, S., Sinatra, R.S. Perioperatiave management of acute pain in the opioid dependent patient. Anesthesiology. 2004;101(1):212–227.

Mohta, M., Kumari, N., Tyagi, A., et al. Tramadol for prevention of postanaesthestic shivering: A randomised double-blind comparison with pethidine. Anaesthesia. 2009;64(2):141–146.

Moinche, S., Kehlet, H., Dahl, J.B. A qualitative and quantitative systematic review of preemptive analgesia for postoperative pain relief. Anesthesiology. 2002;96(3):725–741.

Monitto, C.L., Greenberg, R.S., Kost-Byerly, S., et al. The safety and efficacy of parent-/nurse-controlled analgesia in patients less than six years of age. Anesthesia and Analgesia. 2000;91(3):573–579.

Monk, T.G., Parker, R.K., White, P.F. Use of PCA in geriatric patients: Effect of aging on the postoperative analgesic requirement. Anesthesia and Analgesia. 1990;70:S272.

Monsivals, D., McNeill, J. Multicultural influences on pain medication attitudes and beliefs in patients with nonmalignant chronic pain syndromes. Pain Management Nursing. 2007;8(2):64–71.

Moore, B.A., Kalff, J.C., Bauer, A.J. Molecular and cellular inflammatory mechanisms in the development of postoperative ileus. Sem Colon Rec Surg. 2005;16(4):184–187.

Morita, T., Takigawa, C., Onishi, H., et al. Opioid rotation from morphine to fentanyl in delirious cancer patients: An open-label trial. Journal of Pain and Symptom Management. 2005;30(1):96–103.

Morita, T., Tei, Y., Tsunoda, J., et al. Increased plasma morphine metabolites in terminally ill cancer patients with delirium: An intra-individual comparison. Journal of Pain and Symptom Management. 2002;23(2):107–113.

Morita, T., Tsunoda, J., Inoue, S., et al. Effects of high dose opioids and sedatives on survival in terminally ill cancer patients. Journal of Pain and Symptom Management. 2001;21(4):282–289.

Morley, J.S., Makin, M.K. Comments on Ripamonti, et al. Pain. 1997;73(1):114.

Moryl, N., Coyle, N., Foley, K.M. Managing an acute pain crisis in a patient with advanced cancer: “This is as much of a crisis as a code”. JAMA: The Journal of the American Medical Association. 2008;299(12):1457–1467.

Moser, J.D., Caldwell, J.B., Rhule, F.J. No more than necessary: Safety and efficacy of low-dose promethazine. The Annals of Pharmacotherapy. 2006;40(1):45–48.

Moss, D.D., Hansen, D.J. Metoclopramide and extrapyramidal symptoms: A case report. Journal of Perianesthesia Nursing. 2008;23(5):292–299.

Mouallem, M., Schwartz, E., Farfel, Z. Prolonged oral morphine therapy for severe angina pectoris. Journal of Pain and Symptom Management. 2000;19(5):393–397.

Moulin, D.E., Clark, A.J., Gilron, I., et al. Pharmacological management of chronic neuropathic pain—consensus statement and guidelines from the Canadian Pain Society. Pain Research & Management. 2007;12(1):13–21.

Moulin, D.E., Johnson, N.G., Murray-Parsons, N., et al. Subcutaneous narcotic infusions for cancer pain: Treatment outcome and guidelines for use. Canadian Medical Association Journal. 1992;146(6):891–897.

Mousa, S.A. Morphological correlates of immune-mediated peripheral opioid analgesia. Advances in Experimental Medicine and Biology. 2003;521:77–87.

Muellejans, B., Lopez, A., Cross, M.H., et al. Remifentanil versus fentanyl for analgesia based sedation to provide patient comfort in the intensive care unit: A randomized double-blind controlled trial [ISRCTN43755713]. Critical Care (London, England). 2004;8(1):R1–R11.

Mularski, R.A., Puntillo, K., Varkey, B., et al. Pain management within the palliative care and end-of-life care experience in the ICU. Chest. 2009;135(5):1360–1369.

Muller, S., Zalunardo, M.P., Hubner, M., et al. A fast-track program reduces complicaitons and length of hospital stay after open colonic surgery. Gastroenterology. 2009;136(3):842–847.

Mullins, C.R., Wild, T.L. Pain management in a long-term care facility: Compliance with JCAHO standards. Journal of Pain & Palliative Care Pharmacotherapy. 2003;17(2):63–70.

Murphy, D. Applied clinical pharmacology of opioids. In: Shorten G., Carr D.B., Harmon D., Puig M.M., Browne J., eds. Postoperative pain management: An evidence-based guide to practice. Philadelphia: Saunders; 2006:127–136.

Murphy, G.S., Szokol, J.W., Marymont, J.H., et al. The effects of morphine and fentanyl on the inflammatory response to cardiopulmonary bypass in patients undergoing elective coronary artery bypass graft surgery. Anesthesia and Analgesia. 2007;104(6):1334–1342.

Murray, A., Hagen, N.A. Hydromorphone. Journal of Pain and Symptom Management. 2005;29(Suppl. 5):S57–S66.

Murtagh, F.E., Chai, M.O., Donohoe, P., et al. The use of opioid analgesia in end-stage renal disease patients managed without dialysis: Recommendations for practice. Journal of Pain & Palliative Care Pharmacotherapy. 2007;21(2):5–16.

Myles, P.S. The pain visual analog scale: Linear or nonlinear? (Letter). Anesthesiology. 2004;100(3):744.

Mystakidou, K., Katsouda, E., Parpa, E., et al. Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: An overview of its pharmacological and clinical characteristics. The American Journal of Hospice & Palliative Care. 2005;22(3):228–232.

Mystakidou, K., Parpa, E., Tsilika, E., et al. Long-term management of noncancer pain with transdermal therapeutic system-fentanyl. The Journal of Pain. 2003;4(6):298–306.

Mystakidou, K., Parpa, E., Tsilika, E., et al. Pain management of cancer patients with transdermal fentanyl: A study of 1828 step I, II, III transfers. The Journal of Pain. 2004;5(2):119–132.

Mystakidou, K., Tsilika, E., Parpa, E., et al. Long-term cancer pain management in morphine pre-treated and opioid naïve patients with transdermal fentanyl. International Journal of Cancer. 2003;107(3):486–492.

Mythen, M.G. Postoperative gastrointestinal tract dysfunction. Anesthesia and Analgesia. 2005;100(1):196–204.

Nafiu, O.O., Bullough, A.S. Pneumocephalus and headache after epidural analgesia: Should we really be using air? (Letter). Anesthesia and Analgesia. 2007;105(4):1172–1173.

National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Adult Cancer Pain, 2008. http://www.nccn.org/professionals/physician_gls/PDF/pain.pdf [Accessed May 1, 2008].

Nauta, M., Landsmeer, M.L.A., Koren, G. Codeine-acetaminophen versus nonsteroidal anti-inflammatory drugs in the treatment of post-abdominal surgery pain: A systematic review of randomized trials. American Journal of Surgery. 2009;198(2):256–261.

Neal, J.M. Anatomy and physiology of spinal cord injury associated with regional anesthesia and pain medicine. Regional Anesthesia and Pain Medicine. 2008;33(5):423–434.

Neary, P., Delaney, C.P. Alvimopan. Expert Opinion on Investigational Drugs. 2005;14(4):479–488.

Negro, S., Martin, A., Azuara, M.L., et al. Stability of tramadol and haloperidol for continuous subcutaneous infusion at home. Journal of Pain and Symptom Management. 2005;30(2):192–199.

Nelson, J.E., Meier, D.E., Oei, E.J., et al. Self-reported symptom experiences of critically ill cancer patients receiving intensive care. Critical Care Medicine. 2001;29(2):277–282.

Nelson, R., Tse, B., Edwards, S. Systematic review of prophylactic nasogastric decompression after abdominal operations. The British Journal of Surgery. 2005;92(6):673–680.

Nemergut, E.C., Durieux, M.E., Missaghi, N.B., et al. Pain management after craniotomy. Best Practice & Research Clinical Anaesthesiology. 2007;21(4):557–573.

Neruda, B. The search for the originator of the hanging drop technique. Regional Anesthesia and Pain Medicine. 2008;33(3):276–277.

New Hampshire Hospice and Palliative Care Organization Opioid use guidelines, 2009. Available at http://www.nhhpco.org/opioid.htm [Accessed July 30].

Newshan, G., Lefkowitz, M. Transdermal fentanyl for chronic pain in AIDS: A pilot study. Journal of Pain and Symptom Management. 2001;21(1):69–77.

Newton, P.J., Davidson, P.M., Macdonald, P., et al. Nebulized furosemide in the management of dyspnea: Does the evidence support its use? Journal of Pain and Symptom Management. 2008;36(4):424–441.

Nichols, R. Pain management in patients with addictive disease. The American Journal of Nursing. 2003;103(3):87–90.

Nicholson, B., Passik, S.D. Management of chronic noncancer pain in the primary care setting. Southern Medical Journal. 2007;100(10):1028–1036.

Nicholson, B., Ross, E., Weil, A., et al. Treatment of chronic moderate-to-severe non-malignant pain with polymer-coated extended-release morphine sulfate capsules. Current Medical Research and Opinion. 2006;22(3):539–550.

Nielsen, C.K., Ross, F.B., Lotfipour, S., et al. Oxycodone and morphine have distinctly different pharmacological profiles: Radioligand binding and behavioural studies in two rat models of neuropathic pain. Pain. 2007;132(3):289–300.

Nielsen, C.S., Stubhaug, A., Price, D.D., et al. Individual differences in pain sensitivity: Genetic and environmental contributions. Pain. 2008;136(1):21–29.

Nieminen, T.H., Hagelberg, N.M., Saari, T.I., et al. Rifampin greatly reduces the plasma concentrations of intravenous and oral oxycodone. Anesthesiology. 2009;110(6):1371–1378.

Nightingale, J.J., Knight, M.V., Higgins, B., et al. Randomized, double-blind comparison of patient-controlled epidural infusion vs nurse-administered epidural infusion for postoperative analgesia in patients undergoing colonic resection. British Journal of Anaesthesia. 2007;98(3):380–384.

Nikolajsen, L., Ilkjaer, S., Kroner, K., et al. The influence of preamputation pain on postamputation stump and phantom pain. Pain. 1997;72(3):393–405.

Nisbet, A.T., Mooney-Cotter, F. Post opioid induced sedation scales. Validity, reliability, accuracy, and performance in adult non-critical care settings, 2008. [Poster presentation, American Society for Pain Management Nursing National Meeting, Tucson, AZ, September 4–6].

Nisbet, A.T., Mooney-Cotter, F. Selected scales for reporting opioid-induced sedation. Pain Management Nursing. 2009;10(3):154–164.

Nishimori, M., Ballantyne, J.C., Low, J.H. Epidural pain relief versus systemic opioid-based pain relief for abdominal aortic surgery. Cochrane Database of Systematic Reviews (Online). (3):2006. [CD005059].

Nitescu, P., Hultman, E., Appelgren, L., et al. Bacteriology, drug stability and exchange of percutaneous delivery systems and antibacterial filters in long-term intrathecal infusion of opioid drugs and bupivacaine in “refractory” pain. The Clinical Journal of Pain. 1992;8(4):324–337.

Noble, F., Roques, B.P. Protection of endogenous enkephalin catabolism as a natural approach to novel analgesic and antidepressant drugs. Expert Opinion on Therapeutic Targets. 2007;11(2):145–159.

Noble, M., Tregear, S.T., Treadwell, J.R., et al. Long-term opioid therapy for chronic noncancer pain: A systematic review and meta-analysis of efficacy and safety. Journal of Pain and Symptom Management. 2008;35(2):214–228.

Norman, P.H., Daley, M.D., Lindsey, R.W. Preemptive analgesic effects of ketorolac in ankle fracture surgery. Anesthesiology. 2001;94(4):599–603.

North, J., Kapoor, R., Bull, J., et al. Rapid and effective control of breakthrough pain (BTP) and tolerability in cancer patients treated with BEMA (BioErodible MucoAdhesive) fentanyl. The Journal of Pain. 2008;9(4, Suppl. 1):P23.

Nugent, M., Davis, C., Brooks, D., et al. Long-term observations of patients receiving transdermal fentanyl after a randomized trial. Journal of Pain and Symptom Management. 2001;21(5):385–391.

Nunez, S., Lee, J.S., Zhang, Y., et al. Role of peripheral mu-opioid receptors in inflammatory orofacial muscle pain. Neuroscience. 2007;146(3):1346–1354.

Nunley, C., Wakim, J., Guinn, C. The effects of stimulation of acupressure point p6 on postoperative nausea and vomiting: A review of the literature. Journal of Perianesthesia Nursing. 2008;23(4):247–261.

Odom-Forren, J., Watson, D. Practical guide to moderate sedation/analgesia. St. Louis: Mosby, 2005.

Office of Drug Control Policy (ODCP). Proper disposal of prescription drugs, 2007. http://www.whitehousedrugpolicy.gov/news/press07/022007.html [Accessed April 12, 2008].

Okamoto, Y., Tsuneto, S., Matsuda, Y., et al. A retrospective chart review of the antiemetic effectiveness of risperidone in refractory opioid-induced nausea and vomiting in advanced cancer patients. Journal of Pain and Symptom Management. 2007;34(2):217–222.

Okon, T.R., George, M.L. Fentanyl-induced neurotoxicity and paradoxic pain. Journal of Pain and Symptom Management. 2008;35(3):327–333.

Olson, D.W., Lynn, M., Thoyre, S.M., et al. The limited reliability of the Ramsay Scale. Neurocritical Care. 2007;7(3):227–231.

O’Malley-Dafner, L., Davies, P. Naloxone-induced pulmonary edema. The American Journal of Nursing. 2000;100(11):24AA. [24JJ].

Ong, C.K.S., Lirk, P., Seymour, R.A., et al. The efficacy of preemptive analgesia for acute postoperative pain management: A meta-analysis. Anesthesia and Analgesia. 2005;100(3):757–773.

Osborn, D.A., Jeffery, HE., Cole, M.J. Opiate treatment for opiate withdrawal in newborn infants. Cochrane Database of Systematic Reviews (Online). (3):2005. [CD002059].

Osborn, D.A., Jeffery, H.E., Cole, M.J. Sedatives for opiate withdrawal in newborn infants. Cochrane Database of Systematic Reviews (Online). (3):2005. [CD002053].

Ostrop, N.J., Lamb, J., Reid, G. Intravaginal morphine: An alternative route of administration. Pharmacotherapy. 1998;18(4):863–865.

Overdyk, F., Ahmed, Q. Postoperative monitoring of obese patients with obstructive sleep apnea. (Letter). Anesthesia and Analgesia. 2009;108(3):1044–1045.

Overdyk, F., Carter, R., Maddox, R.R. New JCAHO pain standard bigger threat to patient safety than envisioned. (Letter). Anesthesie Analgesie. 2006;102:1596.

Overdyk, F., Carter, R., Maddox, R.R., et al. Continuous oximetry/capnography monitoring reveals frequent desaturation and bradypnea during patient-controlled analgesia. Anesthesia and Analgesia. 2007;105(2):412–418.

Owen, H., Plummer, J.L., Armstrong, I., et al. Variables of patient-controlled analgesia. 1: Bolus size. Anaesthesia. 1989;44(1):7–10.

Paech, M.J., Moore, J.S., Evans, S.F. Meperidine for patient-controlled analgesia after cesarean section. Anesthesiology. 1994;80(6):1268–1276.

Paech, M.J., Pavy, T.J.G., Orlikowski, C.E.P., et al. Postoperative intraspinal opioid analgesia after caesarean section; a randomised comparison of subarachnoid morphine and epidural pethidine. International Journal of Obstetric Anesthesia. 2000;9(4):238–245.

Paech, M.J., Rucklidge, M.W.M., Lain, J., et al. Ondansetron and dexamethasone dose combinations for prophylaxis against postoperative nausea and vomiting. Anesthesia and Analgesia. 2007;104(4):808–814.

Page, G. Immunologic effects of opioids in the presence or absence of pain. Journal of Pain and Symptom Management. 2005;29(5S):S25–W31.

Paice, J.A. Pharmacokinetics, pharmacodynamics, and pharmacogenomics of opioids. Pain Management Nursing. 2008;8(3, Suppl. 1):S2–S5.

Paice, J.A., Noskin, G.A., Vanagunas, A., et al. Efficacy and safety of scheduled dosing of opioid analgesics: A quality improvement study. The Journal of Pain. 2005;6(10):639–643.

Paice, J.A., Von Roenn, J.H., Hudgins, J.C., et al. Morphine bioavailability from a topical gel formulation in volunteers. Journal of Pain and Symptom Management. 2008;35(3):314–320.

Paice, J.A., Williams, A.R. Intraspinal drugs for pain. In: McGuire D., Yarbro C.H., Ferrell B.R., eds. Cancer pain management. 2nd ed. Boston: Jones, Bartlett Publishers; 1995:131–158.

Paiste, J., Bjerke, R.J., Williams, J.P., et al. Minimally invasive direct coronary artery bypass surgery under high thoracic epidural. Anesthesia and Analgesia. 2001;93(6):1486–1488.

Palacioz, K. Inappropriate meperidine use. Pharm Letters. 17, 2001. [document 171117-8].

Palangio, M., Northfelt, D.W., Portenoy, R.K., et al. Dose conversion and titration with a novel, once-daily, OROS technology, extended-release hydromorphone formulation in the treatment of chronic malignant or nonmalignant pain. Journal of Pain and Symptom Management. 2002;23(5):355–368.

Palm, S., Lehzen, S., Mignat, C., et al. Does prolonged oral treatment with sustained-release morphine tablets influence immune function? Anesthesia and Analgesia. 1998;86:166–172.

Palmer, S.N., Giesecke, N.M., Body, S.C., et al. Pharmacogenetics of anesthetic and analgesic agents. Anesthesiology. 2005;102(3):663–671.

Pan, H., Zhang, Z., Zhang, Y., et al. Efficacy and tolerability of oxycodone hydrochloride controlled-release tablets in moderate to severe cancer pain. Clinical Drug Investigation. 2007;27(4):259–267.

Pan, P.H., Lee, S.C., Harris, L.C. Antiemetic prophylaxis for postdischarge nausea and vomiting and impact on functional quality of living during recovery in patients with high emetic risks: A prospective randomized, double-blind comparison of two prophylactic antiemetic regimens. Anesthesia and Analgesia. 2008;107(2):429–438.

Pandey, C.K., Raza, M., Ranjan, R., et al. Intravenous lidocaine 0.5 mg.kg-1 effectively suppresses fentanyl-induced cough. Canadian Journal of Anesthesia. 2005;52(2):172–175.

Panjabi, S.S., Panjabi, R.S., Shepherd, M.D., et al. Extended-release, once-daily morphine (Avinza) for the treatment of chronic nonmalignant pain: Effect on pain, depressive symptoms, and cognition. Pain Medicine (Malden, Mass.). 2008;9(8):985–993.

Pantanwala, A.E., Jarzyna, D.L., Miller, M.D., et al. Comparison of opioid requirements and analgesic response in opioid-tolerant versus opioid-naïve patients after total knee arthroplasty. Pharmacotherapy. 2008;28(12):1453–1460.

Paqueron, X., Lumbroso, A., Mergoni, P., et al. Is morphine-induced sedation synonymous with analgesia during intravenous morphine titration? British Journal of Anaesthesia. 2002;89(5):687–701.

Park, W.Y., Thompson, J.S., Lee, K.K., et al. Effect of epidural anesthesia and analgesia on perioperative outcome. Annals of Surgery. 2001;234(4):560–569.

Parker, R.K., Holtmann, B., White, P.F. Patient-controlled analgesia: Does a concurrent opioid infusion improve pain management after surgery? JAMA: The Journal of the American Medical Association. 1991;266(14):1947–1952.

Parker, R.K., Holtmann, B., White, P.F. Patient-controlled epidural analgesia: Interactions between nalbuphine and hydromorphone. Anesthesia and Analgesia. 1997;84(4):757–763.

Parker, R.K., Sawaki, Y., White, P.F. Epidural patient-controlled analgesia: influence of bupivacaine and hydromorphone basal infusion on pain control after cesarean section. Anesthesia and Analgesia. 1992;75(5):740–746.

Parker, R.K., White, P.F. Epidural patient-controlled analgesia: an alternative to intravenous patient-controlled analgesia for pain relief after cesarean section. Anesthesia and Analgesia. 1992;75(2):245–251.

Parpaglioni, R., Baldassini, B., Barbati, G., et al. Adding sufentanil to levobupivacaine or ropivacaine intrathecal anaesthesia affects the minimum local anesthetic dose required. Acta Anaesthesiologica Scandinavica. 2009;53(9):1214–1220.

Parramon, F., Garcia, C.H., Gambus, P., et al. Postoperative patient-controlled analgesia is more effective with epidural methadone than with intravenous methadone in thoracic surgery. Revista Espanola de Anesthesiologia Reanimacion. 2003;50(7):326–331.

Parris-Piper, T. Post caesarean delivery pain management: Do not dismiss pethidine. International Journal of Obstetric Anesthesia. 2008;17(1):95–96.

Pasero, C. Multimodal analgesia in the PACU. Journal of Perianesthesia Nursing. 2003;18(4):265–268.

Pasero, C. Fentanyl for acute pain management. Journal of Perianesthesia Nursing. 2005;20(4):279–284.

Pasero, C. Procedure-specific pain management: PROSPECT. Journal of Perianesthesia Nursing. 2007;22(5):335–340.

Pasero, C. Challenges in pain assessment. Journal of Perianesthesia Nursing. 2009;24(1):50–54.

Pasero, C. Assessment of sedation during opioid administration for pain management. Journal of Perianesthesia Nursing. 2009;24(3):186–190.

Pasero, C., Belden, J. Evidence-based perioperative care: Accelerated postoperative recovery programs. Journal of Perianesthesia Nursing. 2006;21(3):168–177.

Pasero, C., Eksterowicz, N., Primeau, M., et al. Registered nurse management and monitoring of analgesia by catheter techniques. Pain Management Nursing. 2007;8(2):48–54.

Pasero, C., Manworren, R.C.B., McCaffery, M. IV Opioid range orders for acute pain management. The American Journal of Nursing. 2007;107(2):52–59.

Pasero, C., McCaffery, M. Unconventional PCA: Making it work for your patient. The American Journal of Nursing. 1993;93(9):38–41.

Pasero, C., McCaffery, M. Multimodal balanced analgesia in the critically ill. Critical Care Nursing Clinics of North America. 2001;13(2):195–206.

Pasero, C., McCaffery, M. Monitoring sedation. The American Journal of Nursing. 2002;102(2):67–69.

Pasero, C., McCaffery, M. Accountability for pain relief: Use of comfort-function goals. Journal of Perianesthesia Nursing. 2003;18(1):50–52.

Pasero, C., McCaffery, M. Safe use of a continuous infusion with IV PCA. Journal of Perianesthesia Nursing. 2004;19(1):42–45.

Pasero, C., McCaffery, M. Authorized and unauthorized use of PCA pumps. The American Journal of Nursing. 2005;105(7):30–33.

Pasero, C., McCaffery, M. Extended-release epidural morphine (Depodur™). Journal of Perianesthesia Nursing. 2005;20(5):345–350.

Pasero, C., McCaffery, M. Orthopaedic postoperative pain management. Journal of Perianesthesia Nursing. 2007;22(3):160–173.

Pasero, C., Portenoy, R.K., McCaffery, M. Opioid analgesics. In: McCaffery M., Pasero C., eds. Pain: Clinical manual. 2nd ed. St. Louis: Mosby; 1999:161–299.

Passik, S.D., Kirsh, K.L. Opioid therapy in patients with a history of substance abuse. CNS drugs. 2004;18(1):13–25.

Pasternak, G.W. Incomplete cross tolerance and multiple mu opioid peptide receptors. Trends in Pharmacological Sciences. 2001;22(2):67–70.

Pasternak, G.W. Molecular biology of opioid analgesia. Journal of Pain and Symptom Management. 2005;29(5S):S2–S9.

Pasternak, G.W. Molecular insights into μ opioid pharmacology from the clinic to the bench. The Clinical Journal of Pain. 2010;26(Suppl. 1):S3–S9.

Patanwala, A.E., Jarzyna, D.L., Miller, M.D., et al. Comparison of opioid requirements and analgesic response in opioid-tolerant versus opioid-naïve patients after total knee arthroplasty. Pharmacotherapy. 2008;28(12):1453–1460.

Patt, R.B., Co-proxamol/Propoxyphene: It is the wise doctor who listens to their patients. BMJ (Clinical Research Ed.) 1998. Rapid Response 29 Sep, http://phstwlp1.partners.org:2352/cgi/eletters/315/7122/1565#880 [Accessed March 9, 2008].

Pavis, H., Wilcock, A., Edgecombe, J., et al. Pilot study of nasal morphine-chitosan for the relief of breakthrough pain in patients with cancer. Journal of Pain and Symptom Management. 2002;24(6):598–602.

Payne, R. Recognition and diagnosis of breakthrough pain. Pain Medicine (Malden, Mass.). 2007;8(Suppl. 1):S3–S7.

Payne, R., Mathias, S.D., Pasta, D.J., et al. Quality of life and cancer pain: Satisfaction and side effects with transdermal fentanyl versus oral morphine. Journal of Clinical Oncology. 1998;16(4):1588–1593.

Pearl, M.L., McCauley, D.L., Thompson, J., et al. A randomized controlled trial of early oral analgesia in gynecologic oncology patients undergoing intra-abdominal surgery. Obstetrics Gynecology. 2002;99(5):704–708.

Peck, M., Down, J. Use of sedatives in the critically ill. Anaesth Intens Care Med. 2009;11(1):12–15.

Pedersen, T., Moller, A.M., Pederson, B.D. Pulse oximetry for perioperative monitoring: Systematic review of randomized, controlled trials. Anesthesia and Analgesia. 2003;97(2):426–431.

Peng, P., Tumber, P., Stafford, M., et al. Experience of methadone therapy in 100 consecutive chronic pain patients in a multidisciplinary pain center. Pain Medicine (Malden, Mass.). 2008;9(7):786–794.

Peng, P.W., Tumber, P.S., Gourlay, D. Review article: Perioperative pain management of patients on methadone therapy. Canadian Journal of Anaesthesia. 2005;52(5):513–523.

Peng, Y.R., Sun, W.Z., Mok, M.S. Mini-dose titration of the transdermal fentanyl patch—A novel approach by adjusting the area of absorption. Journal of Pain and Symptom Management. 2005;30(1):7–8.

Penniston, J.H., Gould, E. Oxymorphone extended release for the treatment of chronic low back pain: A retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use. Clinical Therapeutics. 2009;31(2):347–359.

Pereira, J., Lawlor, P., Vigano, A., et al. Equianalgesic dose ratios for opioids. A critical review and proposals for long-term dosing. Journal of Pain and Symptom Management. 2001;22(2):672–687.

Perkins, F.M., Kehlet, H. Chronic pain as an outcome of surgery. Anesthesiology. 2000;93(4):1123–1133.

Perri, M., 3rd., Menon, A.M., Deshpande, A.D., et al. Adverse outcomes associated with inappropriate drug use in nursing homes. The Annals of Pharmacotherapy. 2005;39(3):405–411.

Persec, J., Persec, Z., Bukovic, D., et al. Effects of clonidine preemptive analgesia on acute postoperative pain in abdominal surgery. Collegium Antropologicum. 2007;31(4):1071–1075.

Phillips, T.W., Broussard, D.M., Sumrall, W.D., et al. Intraoperative oxygen administration does not reduce the incidence or severity of nausea or vomiting associated with neuraxial anesthesia for cesarean delivery. Anesthesia and Analgesia. 2007;105(4):1113–1117.

Picker, M.J. Discriminative stimulus effects of the mixed-opioid agonist/antagonist dezocine: Cross-substitution by mu and delta opioid agonists. Journal of Pharmacology Experimental Therapeutics. 1997;283(3):1009–1017.

Pirat, A., Tuncay, S.F., Torgay, A., et al. Ondansetron, orally disintegrating tablets versus intravenous injection for prevention of intrathecal morphine-induced nausea, vomiting and pruritus in young males. Anesthesia and Analgesia. 2005;101(5):1330–1336.

Pitsiu, M., Wilmer, A., Bodenham, A., et al. Pharmacokinetics of remifentanil and its major metabolite, remifentanil acid, in ICU patients with renal impairment. British Journal of Anaesthesia. 2004;92(4):493–503.

Pittelkow, M.R., Loprinzi, C.L. Pruritus and sweating in palliative medicine. In: Doyle D., Hanks G., Cherny N.I., Calman K., eds. Oxford textbook of palliative medicine. 3rd ed. New York: Oxford Press; 2004:573–587.

Platt, A., Eckman, J.R., Beasley, J.A., et al. Treating sickle cell pain: An update from the Georgia Comprehensive Sickle Cell Center. The Journal of Emergency Medicine. 2002;28(4):297–303.

Pleuvry, B.J. Physiology and pharmacology of nausea and vomiting. Anaesth Intens Care Med. 2009;10(12):587–601.

Plonk, W.M. Simplified methadone conversion. Journal of Palliative Medicine. 2005;8(3):478–479.

Poobalan, A.S., Bruce, J., King, P.M., et al. Chronic pain and quality of life following open inguinal hernia repair. The British Journal of Surgery. 2001;88(8):1122–1126.

Poobalan, A.S., Bruce, J., Smith, W.C., et al. A review of chronic pain after inguinal herniorrhaphy. The Clinical Journal of Pain. 2003;19(1):48–54.

Portenoy, R.K. Opioid analgesics. In: Portenoy R.K., Kanner R.M., eds. Pain management: Theory and practice. Philadelphia: FA Davis; 1996:249–276.

Portenoy, R.K. Prevalence and characteristics of breakthrough pain in opioid-treated patients with chronic noncancer pain. The Journal of Pain. 2005;7(8):583–591.

Portenoy, R.K., Bennett, D.S., Rauck, R., et al. Prevalence and characteristics of breakthrough pain in opioid-treated patients with chronic noncancer pain. The Journal of Pain. 2006;7(8):583–591.

Portenoy, R.K., Farrar, J.T., Backonja, M.M., et al. Long-term use of controlled-release oxycodone for noncancer pain: Results of a 3-year registry study. The Clinical Journal of Pain. 2007;23(4):287–299.

Portenoy, R.K., Foley, K.M. Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases. Pain. 1986;15(2):171–186.

Portenoy, R.K., Forbes, K., Lussier, D., et al. Difficult pain problems: An integrated approach. In: Doyle D., Hanks G., Cherny N.I., Calman K., eds. Oxford textbook of palliative medicine. 3rd ed. New York: Oxford Press; 2004:438–458.

Portenoy, R.K., Hagen, N.A. Breakthrough pain: Definition, prevalence and characteristics. Pain. 1990;41(3):273–281.

Portenoy, R.K., Maldonado, M., Fitzmartin, R., et al. Oral controlled-release morphine sulfate. Analgesic efficacy and side effects of a 100 mg tablet in cancer pain patients. Cancer. 1989;63(Suppl. 11):2284–2288.

Portenoy, R.K., Sciberras, A., Eliot, L., et al. Steady-state pharmacokinetic comparison of a new, extended-release, once-daily morphine formulation, Avinza, and a twice-daily controlled-release morphine formulation in patients with chronic moderate-to-severe pain. Journal of Pain and Symptom Management. 2002;23(4):292–300.

Portenoy, R.K., Sibirceva, U., Smout, R., et al. Opioid use and survival at the end of life: A survey of a hospice population. Journal of Pain and Symptom Management. 2006;32(6):532–540.

Portenoy, R.K., Taylor, D., Messina, J., et al. A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer. The Clinical Journal of Pain. 2006;22(9):805–811.

Portenoy, R.K., Thomas, J., Moehl Boatwright, M.L., et al. Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: A double-blind, randomized, parallel group, dose-ranging study. Journal of Pain and Symptom Management. 2008;35(5):458–468.

Pouzeratte, Y., Delay, J.M., Brunat, G., et al. Patient-controlled epidural analgesia after abdominal surgery: Ropivacaine versus bupivacaine. Anesthesia and Analgesia. 2001;93(6):1587–1592.

Prager, J., Rauck, R. Paper presented at The Second Joint Scientific Meeting of the APS and the Canadian Pain Society, Vancouver, BC Canada; May 6–9. Oxymorphone extended release for moderate to severe neuropathic pain: An open label, long-term study of safety and effectiveness, 2004.

Prakash, S., Fatima, T., Pawar, M. Patient-controlled analgesia with fentanyl for burn dressing changes. Anesthesia and Analgesia. 2004;99(2):552–555.

Prettyman, J. Subcutaneous or intramuscular? Contronting a parenteral administration dilemma. Medsurg Nursing. 2005;14(2):93–98.

Pricara Nucynta package insert. Pricara, Division of Ortho McNeil Pharmaceuticals, 2008. Available at http://www.nucynta.com/nucynta/assets/Nucynta-PI.pdf [Accessed July 1, 2009].

Priestley, M.C., Cope, L., Halliwell, R., et al. Thoracic epidural anesthesia for cardiac surgery: The effects on tracheal intubation time and length of hospital stay. Anesthesia and Analgesia. 2002;94(2):275–282.

Prieto-Alvarez, P., Tello-Galindo, I., Cuenca-Pena, J., et al. Continuous epidural infusion of racemic methadone results in effective postoperative analgesia and low plasma concentrations. Canadian Journal of Anesthesia. 2002;49(1):25–31.

Prime Therapeutics. Study finds 90 percent of Actiq “lollipop” prescriptions are off-label, 2007. http://www.primetherapeutics.com/pdf/Actiq.pdf [Accessed April 13, 2007].

Prommer, E. Tramadol: Does it have a role in cancer pain management? Journal of Opioid Management. 2005;1(3):131–138.

Prommer, E. Rotating methadone to other opioids: A lesson in the mechanisms of opioid tolerance and opioid-induced pain. Journal of Palliative Medicine. 2006;9(2):488–493.

Prommer, E. Oxymorphone: A review. Supportive Care in Cancer. 2006;14(2):109–115.

Prommer, E. Levorphanol: The forgotten opioid. Supportive Care in Cancer. 2007;15:259–264.

Prommer, E. Levorphanol revisited. Journal of Palliative Medicine. 2007;10(6):1228–1230.

Puntillo, K., Pasero, C., Li, D., et al. Evaluation of pain in the ICU patients. Chest. 2009;135(4):1069–1074.

Puntillo, K.A., White, C., Morris, A.B., et al. Patient’s perceptions and responses to procedural pain: Results from Thunder Project II. American Journal of Critical Care. 2001;10(4):238–251.

Purdue Pharma, L.P. OxyContin prescribing information. Stamford, CT: Purdue Pharma LP; 2007 Available at http://www.purduepharma.com/PI/Prescription/Oxycontin.pdf [Accessed Apr 18, 2008].

Purhonen, S., Turunen, M., Ruohoaho, U.M., et al. Supplemental oxygen dose not reduce the incidence of postoperative nausea and vomiting after ambulatory gynecologic laparoscopy. Anesthesia and Analgesia. 2003;96(1):91–96.

Purkayastha, S., Tilney, H.S., Darzi, A.W., et al. Meta-analysis of randomized studies evaluating chewing gum to enhance postoperative recovery following colectomy. Archives of Surgery. 2008;143(8):788–793.

Qaseem, A., Snow, V., Shekelle, P., et al. Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the end of life: A clinical practice guideline from the American College of Physicians. Annals of Internal Medicine. 2008;148(2):141–146.

Quigley, C. Hydromorphone for acute and chronic pain. Cochrane Database of Systematic Reviews (Online). (1):2002. [CD003447].

Quigley, C. Opioid switching to improve pain relief and drug tolerability. Cochrane Database of Systematic Reviews (Online). (3):2004. [CD004847].

Quigley, C., Wiffen, P. A systematic review of hydromorphone in acute and chronic pain. Journal of Pain and Symptom Management. 2003;5(2):169–178.

Quinlan-Colwell, A., Ballato, S., Holmes, W. Poster Presentation at Connecting the Dots – Geriatric Nursing, Education and Clinical Simulation International Conference, April 2–3, Durham, North Carolina. Exploring the correlation among reports of pain, analgesia and the instance of falling, 2009.

Radnay, P.A., Brodman, E., Mankikar, D., et al. The effect of equianalgesic doses of fentanyl, morphine, meperidine, and pentazocine on common bile duct pressure. Anaesthetist. 1980;29:26–29.

Radnay, P.A., Duncalf, D., Novakovic, M., et al. Common bile duct pressure changes after fentanyl, morphine, meperidine, butorphanol, and naloxone. Anesthesia and Analgesia. 1984;63(4):441–444.

Raffa, R.B., Stone, D.J. Unexceptional seizure potential of tramadol or its enantiomers or metabolites in mice. The Journal of Pharmacology and Experimental Therapeutics. 2008;325(2):500–506.

Raja, S.N., Haythornthwaite, J.A., Pappagallo, M., et al. Opioids versus antidepressants in postherpetic neuralgia. A randomized, placebo-controlled trial. Neurology. 2002;59(7):1015–1021.

Ramsay, M., Savege, T., Simpson, B., et al, Controlled sedation with akphaxolone-alphadolone. BMJ (Clinical Research Ed.), 1974;2(5920):656–659. Ramsay Scale available at http://5jsnacc.umin.ac.jp/How%20to%20use%20the%20Ramsay%20Score%20to%20assess%20the%20level%20of%20ICU%20Sedation.htm [Accessed August 28, 2009].

Raphael, J.H., Southall, J.L., Gnanadurai, T.V., et al. Long-term experience with implanted intrathecal drug administration systems for failed back syndrome and chronic mechanical low back pain. BMC Musculoskeletal Disorders. 2002;3:17.

Rapoport, A.M., Bigal, M.E., Tepper, S.J., et al. Intranasal medications for the treatment of migraine and cluster headache. CNS Drugs. 2004;18(10):671–685.

Rapp, S.E., Egan, K.J., Ross, B.K., et al. A multidimensional comparison of morphine and hydromorphone patient-controlled analgesia. Anesthesia and Analgesia. 1996;82(5):1043–1048.

Rathmell, J.P., Lake, T., Ramundo, M.B. Infectious risk of chronic pain treatments: Injection therapy, surgical implants, and intradiscal techniques. Regional Anesthesia and Pain Medicine. 2006;31(4):346–352.

Rathmell, J.P., Viscomi, C.M., Ashburn, M.A. Management of nonobstetric pain during pregnancy and lactation. Anesthesia and Analgesia. 1997;85(5):1074–1087.

Rauck, R.L., Bookbinder, S.A., Bunker, T.R., et al. The ACTION study: A randomized, open-label, multicenter trial comparing once-a-day extended-release morphine sulfate capsules (Avinza) to twice-a-day controlled-release oxycodone hydrochloride tablets (OxyContin) for the treatment of chronic, moderate to severe low back pain. Journal of Opioid Management. 2006;2(3):155–166.

Rauck, R.L., Bookbinder, S.A., Bunker, T.R., et al. A randomized, open-label, multicenter trial comparing once-a-day Avinza (morphine extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-release tablets for the treatment of chronic, moderate to severe low back pain: Improved physical functioning in the ACTION trial. Journal of Opioid Management. 2007;3(1):35–43.

Rauck, R., Ma, T., Kerwin, R., et al. Titration with oxymorphone extended release to achieve effective long-term pain relief and improve tolerability in opioid-naive patients with moderate to severe pain. Pain Medicine (Malden, Mass.). 2008;9(7):777–785.

Ray, W.A., Fought, R.L., Decker, M.D. Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. American Journal of Epidemiology. 1992;136(7):33–47.

Rayburn, W.F., Smith, C.V., Woods, M.P. Continuous and demand narcotic dosing for patient-controlled analgesia after cesarean section. Anesthesiology Review. 1989;17(5):58–62.

Raymo, L.L, Camejo, M., Fudin, J. Eradicating analgesic use of meperidine in a hospital. American Journal of Health-System Pharmacy: AJHP. 2007;64(11):1150–1152. [1148].

Redelmeier, D. New thinking about postoperative delirium. Canadian Medical Association Journal. 2007;177(4):424.

Rees, D.C., Olujohungbe, A.D., Parker, N.E., et al. Guideline for the management of the acute painful crisis in sickle cell disease. British Journal of Haematology. 2003;120(5):744–752.

Reich, D.L., Timcenko, A., Bodian, C.A., et al. Predictors of pulse oximetry data failure. Anesthesiology. 1996;84(4):859–864.

Reid, C.M., Martin, R.M., Sterne, J.A., et al. Oxycodone for cancer-related pain: Meta-analysis of randomized controlled trials. Archives of Internal Medicine. 2006;166(8):837–843.

Reisfield, G.M., Wilson, G.R. Rational use of sublingual opioids in palliative medicine. Journal of Palliative Medicine. 2007;10(2):465–475.

Reuben, D.B., Mor, V. Dyspnea in terminally ill cancer patients. Chest. 1986;89(2):234–236.

Reynvoet, M.E.J., Cosaert, P.A.J.M., Desmet, M.F.R., et al. Epidural dextran 40 patch for postdural puncture headache. Anaesthesia. 1997;52(9):886–888.

Ribeiro, M.D.C., Joel, S.P., Zeppetella, G. The bioavailability of morphine applied topically to cutaneous ulcers. Journal of Pain and Symptom Management. 2004;27(5):434–439.

Ricard-Hibon, A., Belpomme, V., Chollet, C., et al. Compliance with a morphine protocol and effect on pain relief in out-of-hospital patients. The Journal of Emergency Medicine. 2008;34(3):305–310.

Rickard, C., O’Meara, P., McGrail, M., et al. A randomized controlled trial of intranasal fentanyl vs intravenous morphine for analgesia in the prehospital setting. The American Journal of Emergency Medicine. 2007;25(8):911–917.

Ridley, S. The recognition and early management of critical illness. Annals of the Royal College of Surgeons of England. 2005;87(5):315–322.

Riley, J., Eisenberg, E., Müller-Schwefe, G., et al. Oxycodone: A review of its use in the management of pain. Current Medical Research and Opinion. 2008;24(1):175–192.

Riley, J., Ross, J.R., Rutter, D., et al. No pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alternative opioid in cancer patients. Supportive Care in Cancer. 2006;14(1):56–64.

Riordan, S.W., Beam, K., Okabe-Yamamura, T. Introducing patient-controlled oral analgesia. Nursing. 2004;34(9):20.

Ripamonti, C.I., Bandieri, E. Pain therapy. Critical Reviews in Oncology/Hematology. 2009;70(2):145–159.

Ripamonti, C.I., Campa, T., Fagnoni, E., et al. Normal-release oral morphine startign dose in cancer patients with pain. The Clinical Journal of Pain. 2009;25(5):386–390.

Ripamonti, C.I., Groff, L., Brunelli, C., et al. Switching from morphine to oral methadone in treating cancer pain: What is the equianalgesic dose ratio? Journal of Clinical Oncology. 1998;16(10):3216–3221.

Rittner, H.L., Brack, A. Leukocytes as mediators of pain and analgesics. Current Rheumatology Reports. 2007;9(6):503–510.

Rivara, F.P., MacKenzie, E.J., Jurkovich, G.J., et al. Prevalence of pain in patients 1 year after major trauma. Archives of Surgery. 2008;143(3):282–287.

Roberts, G. A review of the efficacy and safety of opioid analgesics. Nursing in Critical Care. 2004;9(6):277–283.

Robertson, T.M., Hendey, G.W., Stroh, G., et al. Intranasal naloxone is a viable alternative to intravenous naloxone for prehospital narcotic overdose. Prehospital Emergency Care. 2009;13(4):512–515.

Robinson, J.M., Wilkie, D.J., Campbell, B. Sublingual and oral morphine administration. The Nursing Clinics of North America. 1995;30(4):725–743.

Rocker, G.M., Heyland, D.K., Cook, D., et al. Most critically ill patients are perceived to die in comfort during withdrawal of life support: A Canadian multicentre study. Canadian Journal of Anesthesia. 2004;51(6):623–630.

Rockford, M.A., DeRuyter, M.L. Perioperative epidural analgesia. In: Smith H.S., ed. Current therapy in pain. Philadelphia: Saunders; 2009:78–84.

Rodgers, A., Walker, N., Schug, S., et al. Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: Results from overview of randomised trials. BMJ (Clinical Research Ed.). 2008;321(7275):1493.

Rodriguez, R.F., Bravo, L.E., Castro, F., et al. Incidence of weak opioids adverse events in the management of cancer pain: A double-blind comparative trial. Journal of Palliative Medicine. 2007;10(1):56–60.

Rodriguez, R.F., Castillo, J.M., Del Pilar Castillo, M., et al. Codeine/acetaminophen and hydrocodone/acetaminophen combination tablets for the management of chronic cancer pain in adults: A 23-day, prospective, double-blind, randomized, parallel-group study. Clinical Therapeutics. 2007;29(4):581–587.

Rohm, K.D., Boldt, J. Persisting neurological symptoms after uncomplicated intrathecal bupivacaine. (Letter). Anesthesia and Analgesia. 2006;103(4):1047.

Rosati, J., Gallagher, M., Shook, B., et al. Evaluation of an oral patient-controlled analgesia device for pain management in oncology inpatients. The Journal of Supportive Oncology. 2007;5(9):443–448.

Roscoe, J.A., Bushunow, P., Jean-Pierre, P., et al. Acupressure bands are effective in reducing radiation therapy-related nausea. Journal of Pain and Symptom Management. 2009;38(3):381–389.

Rosen, D., DeGaetano, N.P. Perioperative management of opioid-tolerance chronic pain patients. Journal of Opioid Management. 2006;2(6):353–363.

Rosenthal, M., Moore, P., Groves, E., et al. Sleep improves when patients with chronic OA pain are managed with morning dosing of once a day extended-release morphine sulfate (AVINZA): Findings from a pilot study. Journal of Opioid Management. 2007;3(3):145–154.

Rosielle, D.A. Fast fact and concept #166: Once-daily oral morphine formulations, 2007. Available at http://www.eperc.mcw.edu/fastFact/ff_166.htm [Accessed July 3, 2009].

Rosow, C.E., Gomery, P., Chen, T.Y., et al. Reversal of opioid-induced bladder dysfunction by intravenous naloxone and methylnaltrexone. Clinical Pharmacology and Therapeutics. 2007;82(1):48–53.

Ross, F.B., Wallis, S.C., Smith, M.T. Co-administration of sub-antinociceptive doses of oxycodone and morphine produces marked antinociceptive synergy with reduced CNS side-effects in rats. Pain. 2000;84(2–3):421–428.

Ross, J.R., Quigley, C. Transdermal fentanyl: Informed prescribing is essential. European Journal of Pain (London, England). 2003;7(5):481–483.

Roth, C.S., Burgess, D.J. Changing residents’ beliefs and concerns about treating chronic noncancer pain with opioids: Evaluation of a pilot workshop. Pain Medicine (Malden, Mass.). 2008;9(7):890–902.

Roth, S.H., Fleischmann, R.M., Burch, F.X., et al. Around-the-clock controlled-release oxycodone therapy for osteoarthritis-related pain. Archives of Internal Medicine. 2000;160(6):853–860.

Rothwell, M., Pearson, D., Wright, K., et al. Bacterial contamination of PCA and epidural infusion devices. Anaesthesia. 2009;64(7):751–753.

Rowbotham, M.C., Twilling, L., Davies, P.S., et al. Oral opioid therapy for chronic peripheral and central neuropathic pain. The New England Journal of Medicine. 2003;348(13):1223–1232.

Royse, C.F., Royse, A.G., Soeding, P.F., et al. Towards pain free cardiac surgery—High thoracic epidural analgesia. Acute Pain. 2000;3(4):7–14.

Royse, C.F., Soeding, P.F., Royse, A.G. High thoracic epidural analgesia for cardiac surgery: An audit of 874 cases. Anaesthesia and Intensive Care. 2007;35(3):374–377.

Rozans, M., Dreisbach, A., Lertora, J.J.L., et al. Palliative uses of methylphenidate in patients with cancer: A review. Journal of Clinical Oncology. 2002;20(1):335–339.

Rozen, D., DeGaetano, N.P. Perioperative management of opioid-tolerant chronic pain patients. Journal of Opioid Management. 2006;2(6):353–363.

Rudich, Z., Peng, P., Dunn, E., et al. Stability of clonidine in clonidine-hydromorphone mixture from implanted intrathecal infusion pumps in chronic pain patients. Journal of Pain and Symptom Management. 2004;28(6):599–602.

Rudin, A., Lundberg, J.F., Hammarlund-Udenaes, M., et al. Morphine metabolism after major liver surgery. Anesthesia and Analgesia. 2007;104(6):1409–1414.

Rudy, A.C., Coda, B.A., Archer, S.M., et al. A multiple-dose phase I study of intranasal hydromorphone hydrochloride in healthy volunteers. Anesthesia and Analgesia. 2004;99(5):1379–1386.

Ruiz, J.R., Kee, S.S., Frenzel, J.C., et al. The effect of an anatomically classified procedure on antiemetic administration in the postanesthesia care unit. Anesthesia and Analgesia. 2010;110(2):403–409.

Rusch, D., Arndt, C., Martin, H., et al. The addition of dexamethasone to dolasetron or haloperidol for treatment of established postoperative nausea and vomiting. Anaesthesia. 2007;62(8):810–817.

Russell, A.W., Owen, H., Ilsley, A.H., et al. Background infusion with patient-controlled analgesia: Effect on postoperative oxyhaemoglobin saturation and pain control. Anaesthesia and Intensive Care. 1996;21(2):174–179.

Saarialho-Kere, U., Julkunen, H., Mattila, M.J., et al. Psychomotor performance of patients with rheumatoid arthritis: Cross-over comparison of dextropropoxyphene, dextropropoxyphen plus amitriptyline, indomethacin, and placebo. Pharmacology & Toxicology. 1988;63(4):286–292.

Sabatowski, R., Schwalen, S., Rettig, K., et al. Driving ability under long-term treatment with transdermal fentanyl. Journal of Pain and Symptom Management. 2003;25(1):38–47.

Saclarides, T.J. Current choices—good or bad—for the proactive management of postoperative ileus: A surgeon’s view. Journal of Perianesthesia Nursing. 2006;21(Suppl. 2A):S7–S15.

Sah, N., Ramesh, V., Kaul, B., et al. Transdermal scopolamine patch in addition to ondansetron for postoperative nausea and vomiting prophylaxis in patients undergoing ambulatory cosmetic surgery. Journal of Clinical Anesthesia. 2009;21(4):249–252.

Sakai, T., Fukano, T., Sumikawa, K. IV butorphanol reduces analgesia but not pruritus or nausea associated with intrathecal morphine. Canadian Journal of Anesthesia. 2001;48(8):831–832.

Sakuramoto, C., Kanai, I., Matoba, M., et al. Treatment of postoperative pain with thoracic epidural morphine in oral malignant tumor patients. The Clinical Journal of Pain. 1996;12(2):142–144.

Salisbury, E.M., Game, D.S., Al-Shakarchi, I., et al. Changing practice to improve pain control for renal patients. Postgraduate Medical Journal. 2009;85(1):30–33.

Salmon, P., Hall, G.M. PCA: Patient-controlled analgesia or politically correct analgesia? (Editorial). British Journal of Anaesthesia. 2001;87(6):815–818.

Salzman, R.T., Roberts, M.S., Wild, J. Can a controlled-release oral dose form of oxycodone be used as readily as an immediate-release form for the purpose of titrating to stable pain control? Journal of Pain and Symptom Management. 1999;18(4):271–279.

Sanchez-Ledesma, M.J., Lopez-Olaondo, L., Pueyo, F.J., et al. A comparison of three antiemetic combinations for prevention of postoperative nausea and vomiting. Anesthesia and Analgesia. 2002;95(6):1590–1595.

Sanchez del Aguila, M.J., Jones, M.F., Vohra, A. Premixed solutions of diamorphine in ropivacaine for epidural anaesthesia: A study on their long-term stability. British Journal of Anaesthesia. 2003;90(2):179–182.

Sarbu, A., Radulescu, F., Robertson, S., et al. 425: Onset of analgesic effect and plasma levels of a controlled release tramadol (tramadol contramid® once-a-day) 200 mg in patients with acute low back pain. Regional Anesthesia and Pain Medicine. 2007;32(5 Supp. 1):163.

Sarhill, N., Davis, M.P., Walsh, D., et al. Methadone-induced myoclonus in advanced cancer. The American Journal of Hospice & Palliative Care. 2001;18(1):51–53.

Sarhill, N., Walsh, D., Nelson, K.A. Hydromorphone: Pharmacology and clinical applications in cancer patients. Supportive Care in Cancer. 2001;9(2):84–96.

Sasson, M., Shvartzman, P. Fentanyl patch sufficient analgesia for only one day. (Letter). Journal of Pain and Symptom Management. 2006;31(5):389–390.

Sathyan, G., Sivakumar, K., Thipphawong, J., et al. Pharmacokinetic profile of 24-hour controlled-release OROS formulation of hydromorphone in the presence of alcohol. Current Medical Research and Opinion. 2008;24(1):297–305.

Sathyan, G., Xu, E., Thipphawong, J., et al. Pharmacokinetic investigation of dose proportionality with a 24-hour controlled-release formulation of hydromorphone. BMC Clinical Pharmacology. 2007;7:3.

Sathyan, G., Xu, E., Thipphawong, J., et al. Pharmacokinetic profile of a 24-hour controlled-release OROS formulation of hydromorphone in the presence and absence of food. BMC Clinical Pharmacology. 2007;7:2.

Saunders, T.A., Glass, P.S.A. A trial of labor for remifentanil (editorial). Anesthesia and Analgesia. 2002;94(4):771–773.

Savage, S.R. Assessment for addiction in pain-treatment settings. The Clinical Journal of Pain. 2002;18:S28–S38.

Savage, S.R., Schofferman, J. Pharmacological therapies of pain in drug and alcohol addictions. In: Miller N., Gold M., eds. Pharmacological therapies for drug and alcohol addictions. New York: Dekker; 1995:373–409.

Sawynok, J. Topically and peripherally acting analgesics. Pharmacological Reviews. 2003;55(1):1–20.

Schenk, M.R., Putzier, M., Kugler, B., et al. Postoperative analgesia after major spine surgery: Patient-controlled epidural analgesia versus patient-controlled intravenous analgesia. Anesthesia and Analgesia. 2006;103(5):1311–1317.

Schmid, R., Koren, G., Klein, J., et al. The stability of a ketamine-morphine solution. Anesthesia and Analgesia. 2002;94(4):898–900.

Schmittner, J., Krantz, M.J. High-dose methadone and QTc prolongation: Strategies to optimize safety. Journal of Opioid Management. 2006;2(1):49–55.

Schricker, T., Meterissian, S., Wykes, L., et al. Postoperative protein sparing with epidural analgesia and hypocaloric dextrose. Annals of Surgery. 2004;240(5):916–921.

Schug, S.A. The role of COX-2 inhibitors in the treatment of postoperative pain. Journal of Cardiovascular Pharmacology. 2006;47(Suppl. 1):S82–S86.

Schug, S.A., Manopas, A. Update on the role of non-opioids for postoperative pain treatment. Best Practice & Research. Clinical Anaesthesiology. 2007;21(1):15–30.

Schug, S.A., Saunders, D., Kurowski, I., et al. Neuraxial drug administration: A review of treatment options for anaesthesia and analgesia. CNS Drugs. 2006;20(11):917–933.

Schultz, T. K. (Eds.), Principles of addiction medicine (2nd ed., pp. 919–944). Chevy Chase, MD: American Society of Addiction Medicine, Inc.

Schumacher, K.L., West, C., Dodd, M., et al. Pain management autobiographies and reluctance to use opioids for cancer pain management. Cancer Nursing. 2002;25(2):125–133.

Schuster, R., Grewal, N., Greaney, G.C., et al. Gum chewing reduces ileus after elective open sigmoid colectomy. Archives of Surgery. 2006;141(2):174–176.

Schuurmans, J.M., Shortridge-Baggett, L.M., Duursma, S.A. The Delirium Observation Screening Scale: A screening instrument for delirium. Research and Theory for Nursing Practice. 2003;17(1):31–50.

Schuurmans, M.J., Deschamps, P.I., Markham, S.W., et al. The measurement of delirium: A review of scales. Research and Theory for Nursing Practice. 2003;17(3):207–224.

Schwartz, A.E., Matteo, R.S., Ornstein, E., et al. Pharmacokinetics of sufentanil in obese patients. Anesthesia and Analgesia. 1991;73(6):790–793.

Schwarzkopf, K.R.G., Hoff, H., Hartmann, M., et al. A comparison between meperidine, clonidine and urapidil in the treatment of postanesthetic shivering. Anesthesia and Analgesia. 2001;92(1):257–260.

Schwenk, W., Haase, O., Neudecker, J.J., et al. Short term benefits for laparoscopic colorectal resection. Cochrane Database of Systematic Reviews (Online). (3):2005. [CD003145].

Scott, D.G. In the days of patients’ choice, why is the patient being ignored? Lancet. 2005;366(9482):287–288.

Scott, L.J., Perry, C.M. Tramadol: A review of its use in perioperative pain. Drugs. 2000;60(1):139–176.

Scuderi, P.E. PRO: Anatomical classification of surgical procedures improves our understanding of the mechanisms of postoperative nausea and vomiting. (Editorial). Anesthesia and Analgesia. 2010;110(2):410–411.

Scuderi, P.E., James, R.L., Harris, L., et al. Multimodal antiemetic management prevents early postoperative vomiting after outpatient laparoscopy. Anesthesia and Analgesia. 2000;91(6):1408–1414.

Seifert, C.F., Kennedy, S. Meperidine is alive and well in the new millennium: Evaluation of meperidine usage patterns and frequency of adverse drug reactions. Pharmacotherapy. 2004;24(6):776–783.

Sekine, R., Obens, E.A.M.T., Coyle, N., et al. The successful use of parenteral methadone in a patient with a prolonged QTc interval. Journal of Pain and Symptom Management. 2007;34(5):566–569.

Semple, T.J., Macintyre, P.E., Hooper, M. Parenteral codeine. Anaesthesia. 1993;48(6):539–540.

Servin, F.S., Billard, V., Remifentanil and other opioids. Handbook of Experimental Pharmacology, 2008;182:283–311.

Sessler, C.N., Gosnell, M.S., Grap, M.J., et al. The Richmond Agitation-Sedation Scale. Validity and reliability in adult intensive care unit patients. American Journal of Respiratory and Critical Care Medicine. 2002;166(10):1338–1344.

Sevarino, F.B., Pizarro, C.W., Sinatra, R. Sterility of epidural solutions—Recommendations for cost-effective use. Regional Anesthesia and Pain Medicine. 2000;25(4):368–371.

Shaheen, P.E., Walsh, D., Lasheen, W., et al. Opioid equianalgesic tables: Are they all equally dangerous? Journal of Pain and Symptom Management. 2009;38(3):409–417.

Shaiova, L., Berger, A., Blinderman, C.D., et al. Consensus guideline on parenteral methadone use in pain and palliative care. Palliative & Supportive Care. 2008;6(2):165–176.

Shaiova, L., Wallenstein, D. Outpatient management of sickle cell pain with chronic opioid pharmacotherapy. Journal of the National Medical Association. 2004;96(7):984–986.

Shane, R. Risk evaluation and mitigation strategies: Impact on patients, health care providers, and health systems. Am J Health Syst Pharm. 2009;66(24 Suppl 7):S6–S12.

Sharke, C., Geisslinger, G., Lotsch, J. Is morphine-3-glucuronide of therapeutic relevance? Pain. 2005;116(3):177–180.

Sharma, P.T., Sieber, F.E., Zakriya, K.J., et al. Recovery room delirium predicts postoperative delirium after hip-fracture repair. Anesthesia and Analgesia. 2005;101(4):1215–1220.

Sheen, M.J., Ho, S.T., Lee, C.H., et al. Preoperative gabapentin prevents intrathecal morphine-induced pruritus after orthopedic surgery. Anesthesia and Analgesia. 2008;106(6):1868–1872.

Shelley, K., Paech, M.J. The clinical applications of intranasal opioids. Current Drug Delivery. 2008;5(1):55–58.

Sherman, B., Enu, I., Sinatra, R.S. Patient-controlled analgesia devices and analgesic infusion pumps. In: Sinatra R.S., de Leon-Casasola O.A., Ginsberg B., et al, eds. Acute pain management. Cambridge, NY: Cambridge University Press, 2009.

Sheth, H.S., Verrico, M.M., Skledar, S.J., et al. Promethazine adverse events after implementation of a medication shortage interchange. The Annals of Pharmacotherapy. 2005;39(2):255–261.

Shibutani, K., Inchiosa, M.A., Jr., Sawada, K., et al. Accuracy of pharmacokinetic models for predicting plasma fentanyl concentrations in lean and obese surgical patients: Derivation of dosing weight (“pharmacokinetic mass”). Anesthesiology. 2004;101(3):603–613.

Shibutani, K., Inchiosa, M.A., Jr., Sawada, K., et al. Pharmacokinetic mass of fentanyl for postoperative analgesia in lean and obese patients. British Journal of Anaesthesia. 2005;95(3):377–383.

Shirk, M.B., Donahue, K.R., Shirvani, J. Unlabeled uses of nebulized medications. American Journal of Health-System Pharmacy: AJHP. 2006;63(18):1704–1716.

Siddiqi, N., Holt, R., Britton, A.M., et al. Interventions for preventing delirium in hospitalised patients. Cochrane Database of Systematic Reviews (Online). (2):2007. [CD005563].

Sidebotham, D., Dijkhuizen, M.R.J., Schug, S.A. The safety and utilization of patient-controlled analgesia. Journal of Pain and Symptom Management. 1997;14(4):202–209.

Silvasti, M., Pitkanen, M. Patient-controlled epidural analgesia versus continuous epidural analgesia after total knee arthroplasty. Acta Anaesthesiologica Scandinavica. 2001;45(4):471–476.

Simonnet, G. Acute tolerance to opioids: Methodological, theoretical and clinical implications. Pain. 2009;142(1–2):3–4.

Simopoulos, T.T., Smith, H.S., Peeters-Asdourian, C., et al. Use of meperidine in patient-controlled analgesia and the development of a normeperidine toxic reaction. Archives of Surgery. 2002;137(1):84–88.

Simpson, K.H., Jones, I. Intrathecal drug delivery for the management of cancer and noncancer pain. Journal of Opioid Management. 2008;4(5):293–304.

Simpson, R.S., Macintyre, P.E., Shaw, D., et al. Epidural catheter tip cultures: Results of a 4-year audit and implications for clinical practice. Regional Anesthesia and Pain Medicine. 2000;25(4):360–367.

Sinatra, R.S. Peripherally acting mu-opioid-receptor antagonists and the connection between postoperative ileus and pain management: The anesthesiologists’s view and beyond. Journal of Perianesthesia Nursing. 2006;21(Suppl. 2A):S16–S23.

Sinatra, R.S. Oral and parenteral opioid analgesics for acute pain management. In: Sinatra R.S., de Leon-Casasola O.A., Ginsberg B., Viscusi E.R., eds. Acute pain management. Cambridge, New York: Cambridge University Press; 2009:188–203.

Singh, H., Bossard, R.F., White, P.F., et al. Effects of ketorolac versus bupivacaine coadministration during patient-controlled hydromorphone epidural analgesia after thoractotomy procedures. Anesthesia and Analgesia. 1997;84(3):564–569.

Singh, S., Sleeper, R.B., Seifert, C.F. Propoxyphene prescribing among populations older and younger than age 65 in a tertiary care hospital. The Consultant Pharmacist: The Journal of the American Society of Consultant Pharmacists. 2007;22(2):141–148.

Singla, N., Pong, A., Newman, K., et al. Combination oxycodone 5  mg/ibuprofen 400 mg for the treatment of pain after abdominal or pelvic surgery in women: A randomized, double-blind, placebo- and active-controlled parallel-group study. Clinical Therapeutics. 2005;27(1):45–57.

Sittl, R., Likar, R., Nautrup, B.P. Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: Results of a retrospective cohort study. Clinical Therapeutics. 2005;27(2):225–237.

Skaer, T.L. Practice guidelines for transdermal opioids in malignant pain. Drugs. 2004;64(23):2629–2638.

Skaer, T.L. Transdermal opioids for cancer pain. Health and Quality of Life Outcomes. 2006;31(4):24.

Slatkin, N., Hill, W., Finn, A. The safety of BEMA (BioErodible MucoAdhesive) fentanyl use for breakthrough pain (BTP) in cancer patients. The Journal of Pain. 2008;9(4 Suppl. 1):P23.

Slatkin, N., Rhiner, M., Bolton, T.M. Donepezil in the treatment of opioid-induced sedation: Report of six cases. Journal of Pain and Symptom Management. 2001;21(5):425–438.

Slatkin, N., Tormo, V., Ahdieh, H. Paper presented at Neuropathic Pain: Changing Paradigms in Diagnosis and Treatment. An International Congress of NeuPSIG, Madrid, Spain, May 13–16. Neuropathic pain treated with oxymorphone, 2004.

Slatkin, N.E., Xie, F., Messina, J., et al. Fentanyl buccal tablet for relief of breakthrough pain in opioid-tolerant patients with cancer-related chronic pain. The Journal of Supportive Oncology. 2007;5(7):327–334.

Slinger, P., Shennib, H., Wilson, S. Postthoracotomy pulmonary function: A comparison of epidural versus intravenous meperidine infusions. Journal of Cardiothoracic and Vascular Anesthesia. 1995;9(2):128–134.

Sloan, P.A., Barkin, R.L. Oxymorphone and oxymorphone extended release: A pharmacotherapeutic review. Journal of Opioid Management. 2008;4(3):131–144.

Sloan, P., Harmann, S. Ultra-low-dose opioid antagonists to enhance opioid analgesia. Journal of Opioid Management. 2006;2(5):295–304.

Sloan, P., Slatkin, N., Ahdieh, H. Effectiveness and safety of oral extended-release oxymorphone for the treatment of cancer pain: A pilot study. Supportive Care in Cancer. 2005;13(1):57–65.

Smith, H.S. Clinical pharmacology of oxymorphone. Pain Medicine (Malden, Mass.). 2009;10(Suppl. 1):S3–S10.

Smith, M.T. Neuroexcitatory effects of morphine and hydromorphone: Evidence implicating the 3-glucuronide metabolites. Clinical and Experimental Pharmacology & Physiology. 2000;27(7):524–528.

Smith, M.T., South, S.M. The role of morphine-6-glucuronide (M6G) in pain control. Pain Rev. 2001;8(2):171–191.

Smith, T.W., Binning, A.R., Dahan, A. Efficacy and safety of morphine-6-glucuronide (M6G) for postoperative pain relief: A randomized, double-blind study. European Journal of Pain (London, England). 2009;13(2):293–299.

Smith, W.C.S., Bourne, D., Squair, J., et al. A retrospective cohort study of post mastectomy pain syndrome. Pain. 1999;83(1):91–95.

Smythe, M.A., Zak, M.B., O’Donnell, M.P. Patient-controlled analgesia versus patient-controlled analgesia plus continuous infusion after hip replacement surgery. The Annals of Pharmacotherapy. 1996;30(3):224–227.

Soares, L.G. Methadone for cancer pain: What have we learned from clinical studies? The American Journal of Hospice & Palliative Care. 2005;22(3):223–227.

Soares, L., Martins, M., Uchoa, R. Intravenous fentanyl for cancer pain: A “fast titration” protocol for the emergency room. Journal of Pain and Symptom Management. 2003;26(3):876–881.

Soltesz, S., Biedler, A., Silomon, M., et al. Recovery after remifentanil and sufentanil for analgesia and sedation of mechanically ventilated patients after trauma or major surgery. British Journal of Anaesthesia. 2001;86(6):763–768.

Somogyi, A.A., Barratt, D.T., Coller, J.K. Pharmacogenetics of opioids. Clinical Pharmacology and Therapeutics. 2007;81(3):429–444.

South, S.M., Smith, M.T. Analgesic tolerance to opioids. Pain. Clinical Updates. IASP. 2001;9(5):1–9.

Spiegel, B. Meperidine or morphine in acute pancreatitis? (Letter). American Family Physician. 2001;64(2):219.

Staats, P.S., Markowitz, J., Schein, J. Incidence of constipation associated with long-acting opioid therapy: A comparative study. Southern Medical Journal. 2004;97(2):129–134.

Stamenkovic, D.M., Geric, V., Slavkovic, Z., et al. Combined spinal-epidural analgesia vs. intermittent bolus epidural analgesia for pain relief after major abdominal surgery. A prospective, randomised, double blind clinical trial. Intrnational Journal of Clinical Practice. 2008;62(2):255–262.

Stanik-Hutt, J.A., Soeken, K.L., Belcher, A.E., et al. Pain experiences of traumatically injured patients in a critical care setting. American Journal of Critical Care. 2001;10(4):252–259.

Stemp, L.I., Ramsay, M. Oxygen may mask hypoventilation—patient breathing must be ensured. (Letter). APSF Newsletter. 2005;20:80. [(Winter)].

Stevens, B. Pain in infants. In: McCaffery M., Pasero C., eds. Pain: Clinical manual. 2nd ed. St. Louis: Mosby; 1999:626–673.

Stevens, R.A., Ghazi, S.M. Routes of opioid analgesic therapy in the management of cancer pain, 2000. Available at www.medscape.com/viewarticle/408974 [Accessed 1/9/09].

Stiller, C.O., Lundblad, H., Weidenhielm, L., et al. The addition of tramadol to morphine via patient-controlled analgesia does not lead to better post-operative pain relief after total knee arthroplasty. Acta Anaesthesiologica Scandinavica. 2007;51(3):322–330.

Stoker, D.G., Reber, K.R., Waltzman, L.S., et al. Analgesic efficacy and safety of morphine-chitosan nasal solution in patients with moderate to severe pain following orthopedic surgery. Pain Medicine (Malden, Mass.). 2008;9(1):3–12.

St. Onge, S., Fugere, F., Girard, M. Bupivacaine decreases epidural meperidine requirements after abdominal surgery. Canadian Journal of Anesthesia. 1997;44(4):360–366.

Strassels, S.A., McNicol, E., Suleman, R. Pharmacotherapy of pain in older adults. Clinics in Geriatric Medicine. 2008;24(2):275–298.

Strichartz, G.R. Neural phyisology and local anesthetic action. In: Cousins M.J., Bridenbaugh P.O., eds. Neural blockade in clinical anesthesia and management of pain. Philadelphia: Lippincott; 1998:35–54.

Strichartz, G.R., Berde, C.B., Local anesthetics. Miller, R.D., eds. Miller’s anesthesia. St. Louis: Elsevier; 2005;vol. 2:573–603. [6th ed.].

Striebel, H.W., Scheitza, W., Philippi, W., et al. Quantifying oral analgesic consumption using a novel method and comparison with patient-controlled intravenous analgesic consumption. Anesthesia and Analgesia. 1998;86(5):1051–1053.

Strong, W.E. Epidural abscess associated with epidural catheterization: A rare event? Report of two cases with markedly delayed presentation. (Letter). Anesthesiology. 1991;74(5):942–946.

Sudheer, P.S., Logan, C., Terblanche, B., et al. Comparison of the analgesic efficacy and respiratory effects of morphine, tramadol and codeine after craniotomy. Anaesthesia. 2007;62(6):555–560.

Sudlow, C.L.M., Warlow, C.C. Epidural blood patching for preventing and treating post-dural puncture headache. Cochrane Database of Systematic Reviews (Online). (2):2001. [CD001791].

Sumida, S., Lesley, M.R., Hanna, M.N., et al. Meta-analysis of the effect of extended-release epidural morphine versus intravenous patient-controlled analgesia on respiratory depression. Journal of Opioid Management. 2009;5(5):301–312.

Sun, T., Sacan, O., White, P.F., et al. Perioperative versus postoperative celecoxib on patient outcomes after major plastic surgery procedures. Anesthesia and Analgesia. 2008;106(3):950–958.

SUPPORT Principle Investigators. A controlled trial to improve care for seriously ill hospitalized patients. JAMA: The Journal of the American Medical Association. 1995;274(20):1591–1598.

Susce, M.T., Murray-Carmichael, E., de Leon, J. Response to hydrocodone, codeine and oxycodone in a CYP2D6 poor metabolizer. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2006;30(7):1356–1358.

Sutters, K.A., Miaskowski, C., Holdridge-Zeuner, D., et al. A randomized clinical trial of the effectiveness of a scheduled oral analgesic dosing regimen for the management of postoperative pain in children following tonsillectomy. Pain. 2004;110(1–2):49–55.

Sutters, K.A., Miaskowski, C., Holdridge-Zeuner, D., et al. Time-contingent dosing of an opioid analgesic after tonsillectomy does not increase moderate-to-severe side effects in children. Pain Management Nursing. 2005;6(2):49–57.

Swarm, R.A., Karanikolas, M., Cousins, M.J. Doyle D., Hanks G., Cherny N.I., Calman K., eds. Oxford textbook of palliative medicine. 3rd ed.. New York: Oxford Press; 2004:378–396.

Sykes, N., Thorns, A. Sedative use in the last week of life and the implications for end-of-life decision making. Archives of Internal Medicine. 2003;163(93):341–344.

Sykes, N., Thorns, A. The use of opioids and sedatives at end of life. The Lancet Oncology. 2003;4(5):312–318.

Szarvas, S., Chellapuri, R.S., Harmon, D.C., et al. A comparison of dexamethasone, ondansetron, and dexamethasone plus ondansetron as prophylactic antiemetic and antipruritic therapy in patients receiving intrathecal morphine for major orthopedic surgery. Anesthesia and Analgesia. 2003;97(1):259–263.

Taillefer, M.C., Carrier, M., Belisle, S., et al. Prevalence, characteristics, and predictors of chronic nonanginal postoperative pain after a cardiac operation: A cross-sectional study. The Journal of Thoracic and Cardiovascular Surgery. 2006;1131(6):1274–1280.

Tang, R., Evans, H., Chaput, A., et al. Multimodal analgesia for hip arthroplasty. Orthopedic Clinics of North America. 2009;40(3):377–387.

Tarcatu, D., Tamasdan, C., Moryl, N., et al. Are we still scratching the surface? A case of intractable pruritus following systemic opioid analgesia. Journal of Opioid Management. 2007;3(3):167–170.

Tassinari, D., Sartori, S., Tamburini, E., et al. Adverse effects of transdermal opiates treating moderate-severe cancer pain in comparison to long-acting morphine: A meta-analysis and systematic review of the literature. Journal of Palliative Medicine. 2008;11(3):492–501.

Taylor, D.R., The pharmacology of fentanyl and its impact on the management of pain. Medscape Neurology Neurosurgery, 2005;7(2) http://www.medscape.com/viewarticle/518441 [Accessed December 21, 2005].

Taylor, D.R. Fentanyl buccal tablet: Rapid relief from breakthrough pain. Expert Opinion on Pharmacotherapy. 2007;8(17):3043–3051.

Taylor, D.R., Webster, L.R., Chun, S.Y., et al. Impact of breakthrough pain on quality of life in patients with chronic, noncancer pain: Patient perceptions and effect of treatment with oral transmucosal fentanyl citrate (OTFC, Actiq). Pain Medicine (Malden, Mass.). 2007;8(3):281–288.

Taylor, S., Kirton, O.C., Staff, I., et al. Postoperative day one: A high risk period for respiratory events. American Journal of Surgery. 2005;190(5):752–756.

Taylor, S., Voytovich, A.E., Kozol, R.A. Has the pendulum swung too far in postoperative pain control? American Journal of Surgery. 2003;186(5):472–475.

Tennant, F., Hermann, L. Self-treatment with oral transmucosal fentanyl citrate to prevent emergency room visits for pain crises: Patient self-reports of efficacy and utility. Journal of Pain & Palliative Care Pharmacotherapy. 2002;16(3):37–44.

Teno, J.M., Clarridge, B.R., Casey, V., et al. Family perspectives on end-of-life care at the last place of care. JAMA: The Journal of the American Medical Association. 2004;291(1):88–93.

Teoh, W.H., Thomas, E., Tan, H.M. Ultra-low dose combined spinal-epidural anesthesia with intrathecal bupivacaine 3.75,g fpr cesarean delivery. International Journal of Obstetric Anesthesia. 2006;15(4):273–278.

Terlinden, R., Ossig, J., Fliegert, F., et al. Absorption, metabolism, and excretion of 14C-labeled tapentadol HCL in healthy male subjects. European Journal of Drug Metabolism and Pharmacokinetics. 2007;32(2):163–169.

Thakore, B., D’Mello, J., Saksena, S., et al. Comparison of fentanyl and butorphanol for postoperative pain relief with intravenous patient controlled analgesia. Acute Pain. 2009;11(3–4):93–99.

Thipphawong, J.B., Babul, N., Morishige, R.J., et al. Analgesic efficacy of inhaled morphine in patients after bunionectomy surgery. Anesthesiology. 2003;99(3):693–700.

Thomas, J. Opioid-induced bowel dysfunction. Journal of Pain and Symptom Management. 2008;35(1):103–113.

Thomas, J., Karver, S., Cooney, G.A., et al. Methylnaltrexone for opioid-induced constipation in advanced illness. The New England Journal of Medicine. 2008;358(22):2332–2343.

Thomas, Z., Bruera, E. Use of methadone in a highly tolerant patient receiving parenteral hydromorphone. Journal of Pain and Symptom Management. 1995;10(4):315–317.

Thompson, D.R. Narcotic analgesic effects on the sphincter of Oddi: A review of the data and therapeutic implications in treating pancreatitis. The American Journal of Gastroenterology. 2001;96(4):1266–1272.

Thorns, A., Sykes, N. Opioid use in last week of life and implications for end-of-life decision making. (Research Letter). Lancet. 2000;356(9227):398–399.

Thune, A., Baker, R.A., Saccone, G.T.P., et al. Differing effects of pethidine and morphine on human sphincter of Oddi motility. The British Journal of Surgery. 1990;77(9):992–995.

Thwaites, D., McCann, S., Broderick, P. Hydromorphone neuroexcitation. Journal of Palliative Medicine. 2004;7(4):545–550.

Timmers, J., Kalisvaart, K., Schuurmans, M., et al. A review of delirium scales. Tijdschrift Voor Gerontologie en Geriatrie. 2004;35(1):5–14.

Titler, M.G., Herr, K., Schilling, M.L., et al. Acute pain treatment for older adults hospitalized with hip fracture: Current nursing practices and perceived barriers. Applied Nursing Research: ANR. 2003;16(4):211–217.

Todd, J., Rees, E., Gwilliam, B., et al. An assessment of the efficacy and tolerability of a ‘double dose’ of normal-release morphine sulphate at bed-time. Palliative Medicine. 2002;16(6):507–512.

Toombs, J.D., Oral methadone dosing for chronic pain: A practitioner’s guide. Pain Treatment Topics 2008. Available at http://pain-topics.org/pdf/OralMethadoneDosing.pdf [Accessed July 31, 2009].

Trafton, J.A., Ramani, A. Methadone: A new old drug with promises and pitfalls. Current Pain and Headache Reports. 2009;13(1):24–30.

Traynor, K. Close vote by FDA advisers favors propoxyphene withdrawal, 2009. http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3037 [Accessed June 22, 2009].

Treece, P.D., Engelberg, R.A., Crowley, L., et al. Evaluation of a standardized order form for the withdrawal of life support in the intensive care unit. Critical Care Medicine. 2004;32(5):1141–1148.

Trissel, A.L., Pham, L. Physical and chemical stability of low and high concentrations of morphine sulfate and bupivacaine hydrochloride packaged in plastic syringes. Int J Pharm Compounding. 2002;6(1):70–73.

Trissel, A.L., Xu, Q.A., Pham, L. Physical and chemical stability of low and high concentrations of morphine sulfate with clonidine hydrochloride packaged in plastic syringes. Int J Pharm Compounding. 2002;6(1):66–69.

Troster, A., Sittl, R., Singler, B., et al. Modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by paracoxib in humans. Anesthesiology. 2006;105:1016–1023.

Tsui, S.L., Irwin, M.G., Wong, C.M., et al. An audit of the safety of an acute pain service. Anaesthesia. 1997;52(11):1042–1071.

Tu, Y.H., Stiles, L., Allen, L.V. Stability of fentanyl citrate and bupivacaine hydrochloride in portable pump reservoirs. American Journal of Hospital Pharmacy. 1990;47(9):2037–2039.

Tuca, A., Roca, R., Sala, C., et al. Efficacy of granisetron in the antiemetic control of nonsurgical intestinal obstruction in advanced cancer: A phase II clinical trial. Journal of Pain and Symptom Management. 2009;37(2):259–270.

Turnbull, D.K., Shepherd, D.B. Post-dural puncture headache: Pathogenesis, prevention and treatment. British Journal of Anaesthesia. 2003;91(5):718–729.

Turner, J.A., Sears, J.M., Loeser, J.D. Programmable intrathecal opioid delivery systems for chronic noncancer pain: A systematic review of effectiveness and complications. The Clinical Journal of Pain. 2007;23(2):180–195.

Tveita, T., Thoner, J., Klepstad, P., et al. A controlled comparison between single doses of intravenous and intramuscular morphine with respect to analgesic effects and patient safety. Acta Anaesthesiologica Scandinavica. 2008;52(7):920–925.

Twycross R., Wilcock A., eds. Hospice and palliative care formulary USA. Nottingham, UK: Palliativedrugs.com, 2007.

Tzschentke, T.M., De Vry, J., Terlinden, R., et al. Tapentadol hydrochloride. Drugs of the Future. 2006;31(12):1053–1061.

Ungar, J.R., Brandes, D., Reinoehi, B.M., et al. Pain management. In Schwartz G.R., ed.: Principles and practice of emergency medicine, 4th ed., Baltimore, MD: Williams, Wilkins, 1999.

United States Food and Drug Administration (FDA) Safety warnings regarding use of fentanyl transdermal (skin) patches. FDA Public Health Advisory, 2005. Available at http://www.fda.gov/CDER/DRUG/advisory/fentanyl.htm [Accessed April 12, 2008].

United States Food and Drug Administration (FDA) FDA Alert: Death, narcotic overdose, and serious cardiac arrhythmias, 2006. Available at http://www.fda.gov/downloads/ Drugs/DrugSafety/PostmarketDrugSafetyInformationfor PatientsandProviders/UCM142839.pdf [Accessed July 31 2009].

United States Food and Drug Administration (FDA) Use of codeine by some breastfeeding mothers may lead to life-threatening side effects in nursing babies. FDA Public Health Advisory, 2007. Available at http://www.fda.gov/CDER/Drug/advisory/codeine.htm [Accessed January 9, 2008].

United States Food and Drug Administration (FDA) FDA warns of potential serious side effects with breakthrough cancer pain drug, 2007. Available at http://www.fda.gov/bbs/topics/NEWS/2007/NEW01711.html [Accessed April 13, 2007].

United States Food and Drug Administration (FDA) Important information for the safe use of fentanyl transdermal system (patch). FDA Public Health Advisory, 2007. Available at http://www.fda.gov/CDER/DRUG/advisory/fentanyl_2007.htm [Accessed Apil 12, 2008].

United States Food and Drug Administration (FDA) Questions and answers about Onsolis (fentanyl buccal soluble film), 2009. Available at http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm172039.htm [Accessed July 18, 2009].

United States Food and Drug Administration (FDA) Acetaminophen information, 2009. Available at http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm165107.htm, http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm168830.htm [Accessed August 30, 2009].

United States Food and Drug Administration (FDA) Promethazine hydrochloride injection, 2009. Available at http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm182500.htm [Accessed September 20, 2009].

United States Food and Drug Administration Guidance for industry: Format and content of proposed Risk Evaluation and Mitigation Strategies (REMS), REMS assessments, and proposed REMS modifications, 2009. Available at http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryIlnformation/Guidances/UCM184128.pdf [Accessed March 14, 2010].

United States Food and Drug Administration Approved Risk Evaluation and Mitigation Strategies (REMS), 2010. Available at http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm111350.htm. [Accessed March 16, 2010].

United States Pharmacopeia. Patient-controlled analgesia pumps. USP Quality Review. 2004;81:1–3.

University of Arizona Center for Education and Research on Therapeutics Drugs with risk of torsade de pointes, 2009. Available at http://www.azcert.org/medical-pros/drug-lists/bycategory.cfm [Accessed July 30,].

Upton, R.N. Cerebral uptake of drugs in humans. Clinical and Experimental Pharmacology & Physiology. 2007;4(8):695–701.

Urch, C.E., Carr, S., Minton, O. A retrospective review of the use of alfentanil in a hospital palliative care setting. Palliative Medicine. 2004;18(6):516–519.

Vachharajani, N.N., Shyu, W.C., Garnett, W.R., et al. The absolute bioavailability and pharmacokinetics of butorphanol nasal spray in patients with hepatic impairment. Clinical Pharmacology and Therapeutics. 1996;60(3):283–294.

Vadalouca, A., Moka, E., Argyra, E., et al. Opioid rotation in patients with cancer: A review of the current literature. Journal of Opioid Management. 2008;4(4):213–250.

Vadalouca, A.N., Mavromati, P.D., Goudas, L.C., et al. Haemodynamic, endocrine and nociceptive response to gynaecological procedures under epidural local anaesthesia during continuous epidural infusion or bolus epidural fentanyl dosing. Acute Pain. 2000;3(3):1–6.

Vadivelu, N., Hines, R.L. Buprenorphine: A unique opioid with broad clinical applications. Journal of Opioid Managementment. 2007;3(1):49–58.

Vallerand, A., Nowak, L.A. Chronic opioid therapy for nonmalignant pain: The patient’s perspective. Part I—life before and after opioid therapy. Pain Management Nursing. 2009;10(3):165–172.

van den Bosch, J.E., Kalkman, C.J., Vergouwe, Y., et al. Assessing the applicability of scoring systems for predicting postoperative nausea and vomiting. Anaesthesia. 2005;60(4):323–331.

Varadarajan, J.L., Weisman, S.J. Acute pain management in sickle cell disease patients. In: Sinatra R.S., de Leon-Casasola O.A., Ginsberg B., Viscusi E.R., eds. Acute pain management. Cambridge, New York: Cambridge University Press; 2009:550–563.

Vascello, L., McQuillan, R.J. Opioid analgesics and routes of administration. In: de Leon-Casasola O.A., ed. Cancer pain. Pharmacological, interventional and palliative care approaches. Philadelphia: Saunders; 2006:171–193.

Vasisht, N., Stark, J., Finn, A. Dose linearity and absolute bioavailability of BEMA (BioErodible MucoAdhesive) fentanyl in healthy volunteers. The Journal of Pain. 2008;9(4, Suppl. 1):P23.

Vaughn, C.W., Connor, M. In search of a role for the morphine metabolite morphine-3-glucuronide. (Editorial). Anesthesia and Analgesia. 2003;97(2):3111–3112.

Vaurio, L.E., Sands, L.P., Wang, Y., et al. Postoperative delirium: The importance of pain and pain management. Anesthesia and Analgesia. 2006;102(4):1267–1273.

Vermiere, A., Remon, J.P. Stability and compatibility of morphine. International journal of pharmaceutics. 1999;187(1):17–51.

Vevs, A., Backonja, M., Malik, R.A. Painful diabetic neuropathy: Epidemiology, natural history, early diagnosis, and treatment options. Pain Medicine (Malden, Mass.). 2008;9(6):660–674.

Vieira, Z.E., Zsigmond, E.K., Duarte, B., et al. Double-blind comparison of butorphanol and nalbuphine on the common bile duct by ultrasonography in man. International Journal of Clinical Pharmacology and Therapeutics. 1993;31(11):564–567.

Vieira, Z.E., Zsigmond, E.K., Duarte, B., et al. Evaluation of fentanyl and sufentanil on the diameter of the common bile duct by ultrasonography in man: A double-blind, placebo-controlled study. International Journal of Clinical Pharmacology and Therapeutics. 1994;32(6):274–277.

Vielvoye-Kerkmeer, A.P.E., Mattern, C., Uitendaal, M.P. Transdermal fentanyl in opioid-naïve cancer pain patients: An open trial using transdermal fentanyl for the treatment of chronic cancer pain in opioid-naïve patients and a group using codeine. Journal of Pain and Symptom Management. 2000;19(3):185–192.

Vila, H., Smith, R.A., Augustyniak, M.J., et al. The efficacy and safety of pain management before and after implementation of hospital-wide pain management standards: Is patient safety compromised by treatment based solely on numerical pain ratings. Anesthesia and Analgesia. 2005;101(2):474–480.

Villesen, H.H., Banning, A.M., Petersen, R.H., et al. Pharmacokinetics of morphine and oxycodone following intravenous administration in elderly patients. Ther Clin Risk Manag. 2007;3(5):961–967.

Vilming, S.T., Kloster, R., Sandvik, L. When should an epidural blood patch be performed in postlumbar puncture headache? A theoretical approach based on a coher of 79 patients. Cephalagia: An International Journal of Headache. 2005;25(7):523–527.

Virani, R., Malloy, P., Ferrell, B.R., et al. Statewide efforts in promoting palliative care. Journal of Palliative Medicine. 2008;11(7):991–996.

Viscomi, C.M., Rathmell, J.P. Pain management issues in the pregnant patient. In: Ashburn M.A., Rice L.J., eds. The management of pain. New York: Churchill Livingstone; 1998:363–381.

Viscusi, E.R., Gan, T.J., Leslie, J.B., et al. Peripherally acting mu-opioid receptor antagonists and postoperative ileus: Mechanisms of action and clinical applicability. Anesthesia and Analgesia. 2009;1108(6):1811–1822.

Viscusi, E.R., Goldstein, S., Witkowski, T., et al. Alvimopan, a peripherally acting mu-opioid receptor antagonist compared with placebo in postoperative ileus after major abdominal surgery: Results of a randomized, double-blind, controlled study. Surgical Endoscopy. 2006;20(1):64–70.

Viscusi, E.R., Kopacz, D., Hartrick, C.T., et al. Single-dose extended-release epidural morphine for pain following hip arthroplasty. American Journal of Therapeutics. 2006;13(5):423–431.

Viscusi, E.R., Martin, G., Hartrick, C.T., et al. Forty-eight hours of postoperative pain relief after total hip arhtroplasty with a novel, extended-release epidural morphine formulation. Anesthesiology. 2005;102(5):1014–1022.

Voepel-Lewis, T., Marinkovic, A., Kostrzewa, A., et al. The prevalence of and risk factors for adverse events in children receiving patient-controlled analgesia by proxy or patient-controlled analgesia after surgery. Anesthesia and Analgesia. 2008;107(1):70–75.

Volmanen, P., Akural, E.I., Raudaskoski, T., et al. Remifentanil in obstetric analgesia: A dose-finding study. Anesthesia and Analgesia. 2002;94(4):913–917.

Voronov, P., Przybylo, H.J., Jagannathan, N. Apnea in a child after oral codeine: A genetic variant—An ultra-rapid metabolizer. Pediatric Anesthesia. 2007;17(7):684–687.

Vorsanger, G., Xiang, J., Jordan, D., et al. Post hoc analysis of a randomized, double-blind, placebo-controlled efficacy and tolerability study of tramadol extended release for the treatment of osteoarthritis pain in geriatric patients. Clinical Therapeutics. 2007;29(Suppl.):2520–2535.

Vranken, J.H., van Kan, H.J.M., van der Vegt, M.H. Stability and compatibility of a meperidine-clonidine mixture in portable pump reservoirs for the management of cancer pain syndromes. (Letter). Journal of Pain and Symptom Management. 2006;32(4):297–299.

Walder, B., Schafer, M., Henzi, I., et al. Efficacy and safety of patient-controlled opioid analgesia for acute postoperative pain: A quantitative systematic review. Acta Anaesthesiologica Scandinavica. 2001;45(7):795–804.

Waldman, S.D. Epidural abscess associated with epidural catheterization. Anesthesiology (Letter). 1991;75(4):708–709.

Walker, P.W., Palla, S., Pei, B.L., et al. Switching from methadone to a different opioid: What is the equianalgesic dose ratio? Journal of Clinical Oncology. 2008;11(8):1103–1108.

Walker, S.E., Law, S., DeAngelis, C. Stability and compatibility of hydromorphone and ketamine in normal saline. The Canadian Journal of Hospital Pharmacy. 2001;54(2):193–201.

Wallace, M., Moulin, D.E., Rauck, R.L., et al. Long-term safety, tolerability, and efficacy of OROS hydromorphone in patients with chronic pain. Journal of Opioid Management. 2009;5(2):97–105.

Wallace, M., Rauck, R.L., Moulin, D., et al. Once-daily OROS hydromorphone for the management of chronic nonmalignant pain: A dose-conversion and titration study. International Journal of Clinical Practice. 2007;61(10):1671–1676.

Wallace, M.S., Thipphawong, J. Clinical trial results with OROS hydromorphone. Journal of Pain and Symptom Management. 2007;33(Suppl. 2):S25–S32.

Wallenborn, J., Gelbrich, G., Bulst, D., et al. Prevention of postoperative nausea and vomiting by metoclopramide combined with dexamethasone: Randomised double blind multicentre trial. BMJ (Clinical Research Ed.). 2006;333(7563):324–327.

Walsh, D., Tropiano, P.S. Long-term rectal administration of high-dose sustained-release morphine tablets. Supportive Care in Cancer. 2002;10(8):653–655.

Wang, J., Pennefather, S., Russell, G. Low-dose naloxone in the treatment of urinary retention during extradural fentanyl causes excessive reversal of analgesia. (Letter). British Journal of Anaesthesia. 1998;80(4):565–566.

Wang, J.J., Ho, S.T., Uen, Y.H., et al. Small-dose dexamethasone reduces nausea and vomiting after laparoscopic cholecystectomy: A comparison of tropisetron with saline. Anesthesia and Analgesia. 2002;95(1):229–232.

Wang, J.K., Nauss, L.A., Thomas, J.E. Pain relief by intrathecally applied morphine in man. Anesthesiology. 1979;50:149–150.

Warren, D.E. Practical use of rectal medications in palliative care. Journal of Pain and Symptom Management. 1996;11(6):378–387.

Washington State Agency Medical Directors’ Group (AMDG) Interagency guideline on opioid treatment. Olympia, WA: Washington State Department of Labor and Industries; 2007 Summary available at www.guidelines.gov/summary/summary.aspx?doc_id=12243 [Accessed July 28, 2009].

Watanabe, S., Belzile, M., Kuehn, N., et al. Capsules and suppositories of methadone for patients on high-dose opioids for cancer pain: Clinical and economic considerations. Cancer Treatment Reviews. 1996;22:131–136.

Watcha, M.F. The cost-effective management of postoperative nausea and vomiting. (Editorial). Anesthesiology. 2000;92(4):931–933.

Watcha, M.F., White, P.F. Post-operative nausea and vomiting: Do they matter? European Journal of Anaesthesiology. 1995;12(Suppl. 10):18–23.

Watson, C.P.N., Moulin, D., Watt-Watson, J., et al. Controlled-release oxycodone relieves neuropathic pain: A randomized controlled trial in painful diabetic neuropathy. Pain. 2003;105(1–2):71–78.

Watson, D.G., Lin, M., Morton, A., et al. Compatibility and stability of dexamethasone sodium phosphate and ketamine hydrochloride subcutaneous infusions in polypropylene syringes. Journal of Pain and Symptom Management. 2005;30(1):80–86.

Waxler, B., Dadabhoy, Z.P., Stojiljkovic, L., et al. Primer of postoperative pruritus for anesthesiologists. Anesthesiology. 2005;103(1):168–178.

Webb, A., Leong, S. The combination of tramadol and morphine may be recommended for postoperative analgesia. Anesthesia and Analgesia. 2005;101(6):1884–1885.

Webster, L.R., Maximizing safety with methadone and other opioids. Practical Pain Management, 2008;8(3):51–55. Also available at http://pain-topics.org/pdf/Webster-MaximizingOpioidSafety.pdf [Accessed June 25, 2008].

Webster, L.R., Choi, Y., Desai, H., et al. Sleep-disordered breathing and chronic opioid therapy. Pain Medicine (Malden, Mass.). 2008;9(4):425–432.

Webster, L.R., Dove, B. Avoiding opioid abuse while managing pain. North Branch, MN: Sunrise River Press, 2007.

Wedam, E.F., Bigelow, G.E., Johnson, R.E., et al. QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial. Archives of Internal Medicine. 2007;167(22):2469–2475.

Wedel, D.J., Horlocker, T.T. Regional anesthesia in the febrile or infected patient. Regional Anesthesia and Pain Medicine. 2006;31(4):324–333.

Weil, A.J., Nicholson, B., Sasaki, J. Factors affecting dosing regimens of morphine sulfate extended-release (Kadian) capsules. Journal of Opioid Management. 2009;5(1):39–45.

Weiler, J.M., Bloomfield, J.R., Woodworth, G.G., et al. Effects of fexofenadine, diphenhydramine, and alcohol on driving performance: A randomized, placebo-controlled trial in the Iowa Driving Simulator. Annals of Internal Medicine. 2000;132:354–363.

Weinberg, D.S., Inturrisi, C.E., Reidenberg, B., et al. Sublingual absorption of selected opioid analgesics. Clinical Pharmacology and Therapeutics. 1988;44:335–342.

Weinstein, S.M. In patients with chronic pain, what is the suggested maximum dose of sustained-release morphine? Primary Care Cancer. 1994;14(1):15.

Weissman, D.E, Haddox, J.D. Opioid pseudoaddiction—an iatrogenic syndrome. Pain. 1989;36(3):363–366.

Wellington, J., Chia, Y.Y. Patient variables influencing acute pain management. In: Sinatra R.S., de Leon-Casasola O.A., Ginsberg B., Viscusi E.R., eds. Acute pain management. Cambridge, New York: Cambridge University Press; 2009:33–40.

Werawatganon, T., Charuluxananan, S. Patient controlled intravenous opioid analgesia versus continuous epidural analgesia for pain after intra-abdominal surgery. Cochrane Database of Systematic Reviews (Online). (1):2005. [CD004088].

Wermeling, D.P., Clinch, T., Rudy, A.C., et al. A multicenter, open-label, exploratory dose-ranging trial of intranasal hydromorphone for managing acute pain from traumatic injury. Acute Pain. 2009;11(3):151–152.

Wermeling, D.P., Grant, G.M., Lee, A., et al. Analgesic effects of intranasal butorphanol tartrate administered via a unit-dose device in the dental impaction pain model: A randomized, double-blind, placebo-controlled, parallel-group study. Clinical Therapeutics. 2005;27(4):430–440.

Weschules, D.J., Bain, K.T. A systematic review of opioid conversion ratios used with methadone for the treatment of pain. Pain Medicine (Malden, Mass.). 2008;9(5):595–612.

Weschules, D.J., Bain, K.T., Richeimer, S. Actual and potential drug interactions associated with methadone. Pain Medicine (Malden, Mass.). 2008;9(3):315–344.

Westin, U.E., Boström, E., Gråsjö, J., et al. Direct nose-to-brain transfer of morphine after nasal administration to rats. Pharmaceutical Research. 2006;23(3):565–572.

Wheatley, R.G., Shepherd, D., Jackson, I.J., et al. Hypoxaemia and pain relief after upper abdominal surgery: Comparison of IM and patient-controlled analgesia. British Journal of Anaesthesia. 1992;69(6):558–661.

Wheatley, R.G., Schug, S.A., Watson, D. Safety and efficacy of postoperative epidural analgesia. British Journal of Anaesthesia. 2001;87(1):47–61.

Wheeler, M., Oderda, G.M., Ashburn, M.A., et al. Adverse events associated with postoperative opioid analgesia: A systematic review. The Journal of Pain. 2002;3(3):159–180.

White, C., Hardy, J., Boyd, A., et al. Subcutaneous sufentanil for palliative care patients in a hospital setting. Palliative Medicine. 2008;22(1):89–90.

White, P.F. Droperidol: A cost-effective antiemetic for over thirty years. (Editorial). Anesthesia and analgesia. 2002;95(4):789–790.

White, P.F. The changing role of non-opioid analgesic techniques in the management of postoperative pain. Anesthesia and Analgesia. 2005;105(Suppl. 5):S5–S22.

White, P.F., Freire, A.R., Ambulatory (outpatient) anesthesia. Miller, R.D., eds. Miller’s anesthesia, 6th ed., Vol. 2. St. Louis: Elsevier, 2005;2589–2635.

White, P.F., Hamza, M.A., Recart, A., et al. Optimal timing of acustimulation for antiemetic prophylaxis as an adjuct to ondansetron in patients undergoing plastic surgery. Anesthesia and Analgesia. 2005;100(2):367–372.

White, P.F., Issioui, T., Hu, J., et al. Comparative efficacy of acustimulation (ReliefBand®) versus ondansetron in combination with droperidol for preventing nausea and vomiting. Anesthesiology. 2002;97(5):1075–1081.

White, P.F., O’Hara, J.F., Roberson, C.R., et al. The impact of current antiemetic practices on patient outcomes: A prospective study on high-risk patients. Anesthesia and Analgesia. 2008;107(2):452–458.

White, P.F., Sacan, O., Nuangchamnog, N., et al. The relationship between patient risk factors and early versus late postoperative emetic symptoms. Anesthesia and Analgesia. 2008;107(2):459–463.

White, P.F., Song, D., Abrao, J., et al. Effect of low-dose droperidol on the QT interval during and after general anesthesia. Anesthesiology. 2005;102(6):1101–1105.

White, P.F., Tang, J., Song, D., et al. Transdermal scopolamine: An alternative to ondansetron and droperidol for the prevention of postoperative and postdischarge emetic symptoms. Anesthesia and Analgesia. 2007;104(1):92–96.

Wiffen, P.J., McQuay, H.J. Oral morphine for cancer pain. Cochrane Database of Systematic Reviews (Online). (4):2007. [CD003868].

Wilbeck, J., Schorn, M.N., Daley, L. Pharmacologic management of acute pain in breastfeeding women. Journal of Emergency Nursing: JEN. 2008;34(4):340–344.

Wilhelm, S.M., Dehoorne-Smith, M.L., Kale-Pradhan, P.B. Prevention of postoperative nausea and vomiting. The Annals of Pharmacotherapy. 2007;41(1):68–78.

Wilhelm, W., Schlaich, N., Harrer, J., et al. Recovery and neurological examination after remifentanil—desflurane or fentanyl-desflurane anaesthesia for carotid artery surgery. British Journal of Anaesthesia. 2001;86(1):44–49.

Williams, M.A. Delirium/acute confusional states: Evaluation devices in nursing. International Psychogeriatrics/IPA. 1991;3(2):301–308.

Williams-Russo, P., Urquhart, B.L., Sharrock, N.E., et al. Post-operative delirium predictors and prognosis in elderly orthopedic patients. Journal of the American Geriatrics Society. 1992;40(8):759–767.

Wilmore, D.W., Kehlet, H. Management of patients in fast track surgery. BMJ (Clinical Research Ed.). 2001;322(7284):473–476.

Wilmore, D.W., Kehlet, H. Evidence-based surgical care and the evolution of fast-track surgery. Annals of Surgery. 2008;248(2):189–198.

Wilson, A. Regional analgesia and orthopaedic surgery. Orthopaed Trauma. 2009;23(6):441–449.

Wilson, J.M., Cohen, R.I., Kezer, E.A., et al. Single and multiple-dose pharmacokinetics of dezocine in patients with acute and chronic pain. Journal of Clinical Pharmacology. 1995;35(4):395–403.

Wilson, M.J.A., MacArthur, C., Cooper, G.M., et al. Epidural analgesia and breastfeeding: A randomised controlled trial of epidural techniques with and without fentanyl and a non-epidural comparison group. Anaesthesia. 2010;65(2):145–153.

Wilson, W.C., Smedira, N.G., Fink, C., et al. Ordering and administration of sedatives and analgesics during the withholding and withdrawal of life support from critically ill patients. JAMA: The Journal of the American Medical Association. 1992;267(1):949–953.

Wirz, S., Wartenberg, H.C., Elsen, C., et al. Managing cancer pain and symptoms of outpatient rotation to sustained-release hydromorphone. A prospective clinical trial. The Clinical Journal of Pain. 2006;22(9):770–775.

Wirz, S., Whittmann, M., Schenk, M., et al. Gastrointestinal symptoms under opioid therapy: A prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and trandermal buprenorphine. European Journal of Pain (London, England). 2009;13(7):737–743.

Wisner, A., Dufour, E., Messaoudi, M., et al. Human opiorphin, a natural antinociceptive modulator of opioid-dependent pathways. Proceedings of the National Academy of Sciences of the United States of America. 2006;103(47):17979–17984.

Wittels, B., Glosten, B., Faure, E.A.M. Postcesarean analgesia with both epidural morphine and intravenous patient-controlled analgesia: Neurobehavioral outcomes among nursing neonates. Anesthesia and Analgesia. 1997;85(3):600–606.

Wittwer, E., Kern, S.E. Role of morphine’s metabolites in analgesia: Concepts and controversies. The AAPS Journal. 2006;8(2):E348–E352.

Wolfe, T. Intranasal fentanyl for acute pain: Techniques to enhance efficacy. Annals of Emergency Medicine. 2007;49(5):721–722.

Wood, G.J., Shega, J.W., Lynch, B., et al. Management of intractable nausea and vomiting in patients at the end of life. JAMA: The Journal of the American Medical Association. 2007;298(10):1196–1207.

Wood, J.D. Opioids, the enteric nervous system, and postoperative ileus. Sem Colon Rec Surg. 2005;16(4):188–196.

Woodall, H.E., Chiu, A., Weissman, D.E. Opioid allergic reactions #175. Journal of Palliative Medicine. 2008;11(10):1340–1341.

Woolf, C.J. Evidence for a central component of post-injury pain hypersensitivity. Nature. 1983;306(5944):686–688.

Woolf, C.J., Chong, M.S. Preemptive analgesia: Treating postoperative pain by preventing the establishment of central sensitization. Anesthesia and Analgesia. 1993;77(2):362–379.

World Health Organization (WHO). Cancer pain relief. Geneva: WHO, 1986.

World Health Organization (WHO) Cancer Pain Relief. 2nd ed. 1996. Available at http://www.painpolicy.wisc.edu/publicat/cprguid.htm#WHO [Accessed May 15, 2008].

Wright, A.W., Mather, L.E., Smith, M.T. Hydromorphone-3-glucuronide: A more potent neuro-excitant than its structural analogue, morphine-3-glucuronide. Life Sciences. 2001;69(4):409–420.

Wu, C.L., Acute postoperative pain. Miller, R.D., eds. Miller’s anesthesia, 6th ed., Vol. 2. Philadelphia: Elsevier, 2005;2729–2762.

Wuhrman, E., Cooney, M.F., Dunwoody, C.J., et al, Authorized and unauthorized (“PCA by proxy”) dosing of analgesic infusion pumps: Position statement with clinical practice recommendations. Pain Management Nursing, 2007;8(1):4–11. Available at http://www.aspmn.org/Organization/documents/PMNVersionPCA.pdf [Accessed January 14, 2008].

Wulf, H., Gleim, M., Mignat, C. The stability of mixtures of morphine hydrochloride, bupivacaine hydrochloride, and clonidine hydrochloride in portable pump reservoirs for the management of chronic pain syndromes. Journal of Pain and Symptom Management. 1994;9(5):308–311.

Wyeth Pharmaceuticals, Inc. Relistor prescribing information. Philadelphia, PA: Wyeth Pharmaceuticals, Inc, 2009.

Xanodyne Pharmaceuticals. Oramorph SR prescribing information. Newport, KY: Xanodyne Pharmaceuticals, 2008.

Yaksh, T.L., Harty, G.J. Pharmacology of the allodynia in rats evoked by high dose intrathecal morphine. The Journal of Pharmacology and Experimental Therapeutics. 1988;244:501–507.

Yeh, H.M., Chen, L.K., Lin, C.J., et al. Prophylactic intravenous ondansetron reduces the incidence of intrathecal morphine-induced pruritus in patients undergoing cesarean delivery. Anesthesia and Analgesia. 2000;91(1):172–175.

Young-McCaughan, S., Miaskowski, C. Definition of and mechanism for opioid-induced sedation. Pain Management Nursing. 2001;2(3):84–97.

Yu, S.C., Ngan Kee, W.D., Kwan, A.S.K. Addition of meperidine to bupivacaine for spinal anaesthesia for caesarean section. British Journal of Anaesthesia. 2002;88(3):379–383.

Yuan C.S., ed. Handbook of opioid bowel dysfunction. New York: Haworth Medical Press, 2005.

Yuan, C.S., Foss, J.F., O’Connor, M., et al. Efficacy of orally administered methylnaltrexone in decreasing subjective effects after intravenous morphine. Drug and Alcohol Dependence. 1998;52(2):161–165.

Yuan, C.S., Foss, J.F., O’Connor, M., et al. Methylnaltrexone for reversal of constipation due to chronic methadone use. The New England Journal of Medicine. 2000;283(3):367–372.

Yuan, H.B., Zuo, Z., Yu, K.W., et al. Bacterial colonization of epidural catheters used for short-term postoperative analgesia. Anesthesiology. 2008;108(1):130–137.

Zacny, J.P. Should people taking opioids for medical reasons be allowed to work and drive? Addiction (Abingdon, England). 1996;91(11):1581–1584.

Zajaczkowska, R., Wlodzimierz, W., Wordliczek, J., et al. Peripheral opioid analgesia in laparoscopic cholecystectomy. Regional Anesthesia and Pain Medicine. 2004;29(5):424–429.

Zakriya, K.J., Christmas, C., Wenz, J.F., et al. Preoperative factors associated with postoperative change in confusion assessment method score in hip fracture patients. Anesthesia and Analgesia. 2002;94(6):1628–1632.

Zangrillo, A., Bignami, E., Biondi-Zoccai, G.G.L., et al. Spinal analgesia in cardiac surgery: A meta-analysis of randomized controlled trials. Journal of Cardiothoracic and Vascular Anesthesia. 2009;23(6):813–821.

Zaslansky, R., Eisenberg, E., Peskin, B., et al. Early administration of oral morphine to orthopedic patients after surgery. Journal Opioid Management. 2006;2(2):88–92.

Zech, D.F.J., Grond, S.U.A., Lynch, J., et al. Validation of World Health Organization Guidelines for cancer pain relief: A 10-year prospective study. Pain. 1995;63(1):65–76.

Zeppetella, G. An assessment of the safety, efficacy, and acceptability of intranasal fentanyl citrate in the management of cancer-related breakthrough pain: A pilot study. Journal of Pain and Symptom Management. 2000;20(4):253–258.

Zeppetella, G. Nebulized and intranasal fentanyl in the management of cancer-related breakthrough pain. Palliative Medicine. 2000;14(1):57–58.

Zeppetella, G. Opioids for cancer breakthrough pain: A pilot study reporting patient assessment of time to meaningful pain relief. Journal of Pain and Symptom Management. 2008;35(5):563–567.

Zeppetella, G., Porzio, G., Aielli, F. Opioids applied topically to painful cutaneous malignant ulcers in a palliative care setting. Journal of Opioid Management. 2007;3(3):161–166.

Zeppetella, G., Ribeiro, M.D.C. Opioids for the management of breakthrough (episodic) pain in cancer patients. Cochrane Database of Systematic Reviews (Online). (1):2006. [CD004311].

Zhan, C., Sangl, J., Bierman, A.S., et al. Potentially inappropriate medication use in the community-dwelling elderly: Findings from the 1996 Medical Expenditure Panel Survey. JAMA: The Journal of the American Medical Association. 2001;286(22):2823–2829.

Zhang, H., Zhang, J., Streisand, J.B. Oral mucosal drug delivery: Clinical pharmacokinetics and therapeutic applications. Clinical Pharmacokinetics. 2002;41(9):661–680.

Zhao, S.Z., Chung, F., Hanna, D.B., et al. Dose-response relationship between opioid use and adverse effects after ambulatory surgery. Journal of Pain and Symptom Management. 2004;28(1):35–46.

Zhou, S., Chan, E., Pan, S.Q., et al. Pharmacokinetic interactions of drugs with St John’s wort. Journal of Psychopharmacology (Oxford, England). 2004;18(2):262–276.

Zimmermann, C., Seccareccia, D., Booth, C.M., et al. Rotation to methadone after opioid dose escalation: How should individualization of dosing occur? Journal of Pain & Palliative Care Pharmacotherapy. 2005;19(2):25–31.

Zsigmond, E.K., Vieira, Z.E., Duarte, B., et al. Double-blind placebo-controlled ultrasonographic confirmation of constriction of the common bile duct by morphine. International Journal of Clinical Pharmacology, Therapy, and Toxicology. 1993;31(10):506–509.